Sergio Chimenti - Policlinico Tor Vergata

Transcript

Sergio Chimenti
Curriculum Vitae
CURRICULUM VITAE
INFORMAZIONI PERSONALI:
Luogo e data di nascita:
Roma, 09/05/1949
Indirizzo:
Telefono:
0620902743
Cellulare:
Fax:
0620902742
E-mail:
[email protected]
Cittadinanza: italiana
Occupazione:
-
Medico-Chirurgo specializzato in Dermatologia e Venereologia
-
Professore Ordinario della Cattedra di Dermatologia e Venereologia,
presso la Facoltà di Medicina e Chirurgia dell’Università degli Studi di
Roma “Tor Vergata”
-
Direttore della U.O.C. di Dermatologia e Venereologia presso il
Policlinico Tor Vergata, Roma.
ISTRUZIONE, FORMAZIONE ED ESPERIENZE PERSONALI
-
Laurea in Medicina e Chirurgia presso l'Università degli Studi di Roma "La Sapienza",
conseguita il 05/11/1973 con votazione 110/110 e lode.
-
Medico presso l'Istituto di Dermatologia dell’Università degli Studi di Roma "La Sapienza"
dal 08/11/1973.
-
Docente di Medicina presso il Dipartimento di Dermatologia dell’Università degli Studi di
Roma "La Sapienza" dal 16/11/1974.
-
Specializzazione in Clinica Dermosifilopatica presso l’Università degli Studi di Roma "La
Sapienza, conseguita il 15/06/1976 con votazione 70/70 e lode.
-
Professore assistente presso il Dipartimento di Dermatologia dell’Università degli Studi di
Roma "La Sapienza" dal 10/05/1977.
-
È stato Giudicato idoneo nella prima tornata di giudizio di idoneità per Professore Associato
tenutasi il 09/01/1982.
-
Vincitore del concorso di Professore di ruolo di I fascia presso l'Università degli Studi de
L'Aquila per la disciplina “Dermatologia e Venereologia” nel 1985.
-
Presidente del Consiglio del Corso di Laurea in Odontostomatologia presso Università degli
Studi de L’Aquila dal 1986 al 1988.
-
Direttore della Scuola di Specializzazione in Dermatologia e Venereologia dell'Università
degli Studi de L'Aquila dal 1987 al 1999.
-
Direttore e fondatore della Scuola per Tecnici Cosmetici presso Università degli Studi de
L’Aquila dal 1989 al 1998.
-
Docente presso l'Università di Yale, New Haven, Connecticut, Stati Uniti d'America dal
1992.
-
Consulente di Oncologia Cutanea presso l'Istituto Dermatologico Santa Maria e San
Gallicano, IRCCS, Roma dal giugno 1995 al dicembre 1995.
-
Professore Ordinario Cattedra di Dermatologia e Venereologia presso la Facoltà di Medicina
e Chirurgia dell’Università degli Studi di Roma “Tor Vergata” e Direttore della U.O.C. di
Dermatologia e Venereologia presso il Policlinico Tor Vergata di Roma dal 1999.
-
Membro della Società Italiana di Dermatologia e Venereologia dal 1974.
-
Membro dell’Accademia Lancisiana dal 1976.
-
Membro della Società Internazionale di Dermatopatologia dal 1980.
-
Membro con ruolo esecutivo della Società Internazionale di Chirurgia dermatologica dal
1980.
-
Membro dell’Accademia Medica Romana dal 1984.
-
Membro del Consiglio della Società Internazionale di Dermatopatologia dal 1988.
-
Membro dell’EORTC (European Organization for Research and Treatment of Cancer)
Lymphoma Study Group dal 1991.
-
Fondatore e membro accademico dell’Accademia Medica de L’Aquila dal 1991.
-
Membro con ruolo esecutivo della Società Internazionale per lo Studio del linfoma cutaneo
dal 1992.
-
Membro dell’ESDR (European Society for Dermatological Research) dal 1994.
-
Membro del Comitato di Redazione della rivista "Acta Dermatovenerologica Alpina,
Panonica et Adriatica" dal 1995.
-
Membro fondatore del Consiglio della Società Europea di Dermatopatologia dal 1996.
-
Membro del Consiglio dell’Associazione Europea di Dermato-Oncologia dal 2000.
-
Chiamato dal Ministro della Salute a far parte del Consiglio Superiore di Sanità in qualità di
esperto dal 2001.
-
Membro del Forum Dermatologico Europeo dal 2003.
-
Membro fondatore dell’International Dermoscopy Society (IDS) dal 2004.
-
Membro fondatore della Società Internazionale di Teledermatologia dal 2004.
-
Nominato esperto dell’Agenzia Italiana del Farmaco (A.I.F.A.) dal 2004.
CAPACITA’ E COMPETENZE PERSONALI
Madrelingua: Italiano
Altre lingue: Eccellente conoscenza delle lingue Inglese e Francese sia scritte che parlate
Informatica: Ottime competenze tecniche nell’uso di Word, Excel, Outlook, Internet Explorer,
Power Point.
Apparecchiature Mediche: Epiluminescenza, Dermoscopia, Laser, Elettrobisturi and Devices
Elettronici.
CAPACITA’ E COMPETENZE ORGANIZZATIVE
-
Laboratorio di Istopatologia Cutanea presso la Clinica Dermatologica dell’Università degli
Studi de L’Aquila dal 1990.
-
Laboratorio di Biologia Molecolare presso la Clinica Dermatologica dell’Università degli
Studi de L’Aquila dal 1990.
-
Laboratorio di Cosmetologia presso la Scuola Diretta a Fini Speciali per Tecnici Cosmetici
dell’Università degli Studi de L’Aquila dal 1990.
-
Centro per la prevenzione e la cura delle lesioni pigmentate presso la Clinica Dermatologica
dell’Università degli Studi de L’Aquila dal 1991.
-
Centro della Psoriasi persso la Clinica Dermatologica dell’Università degli Studi di Roma
“Tor Vergata” dal 2000.
-
Day Hospital Dermatologico persso l’Ospedle S. Eugenio di Roma dal 2001.
-
Centro di Camoufflage Dermatologico presso l’Ospedale S. Eugenio di Roma dal 2002.
-
Sovraintendente all’attività del reparto di Dermatologia dell’Università degli Studi di Roma
“Tor Vergata” dal 2002.
PRINCIPALI CAMPI DI INTERESSE:
Dermatopatologia, Oncologia (linfomi cutanei e melanoma), Malattie infiammatorie croniche
cutanee, Psoriasi, Malattie autoimmunitarie, Teledermatologia
Total IF: 926.221
H-Index: 35
Citations: 6979
References: 4745
BIBLIOGRAFIA:
[On the use in dermatological patients of a macrolide antibiotic: triacetyloleandomycin (author's
transl)].
Chimenti S, Faina P, Provini M.
Antibiotica. 1973 Jun;11(2):67-76. English, Italian. No abstract available.
[Therapeutic activity of aminaphthone in purpuric disorders].
Chimenti S, Faina P.
Clin Ter. 1978 Mar 15;84(5):501-8. Italian. No abstract available.
Is subcorneal pustular dermatosis of Sneddon and Wilkinson an entity sui generis?
Chimenti S, Ackerman AB.
Am J Dermatopathol. 1981 Winter;3(4):363-76. Review. No abstract available.
Malignant melanoma of the oral cavity.
Chimenti S, Calvieri S, Ribuffo M.
J Dermatol Surg Oncol. 1981 Mar;7(3):220-4.
Synovial sarcoma of the foot.
Chimenti S, Calvieri S, Ribuffo M.
J Dermatol Surg Oncol. 1982 Oct;8(10):882-6. No abstract available.
Kaposi's sarcoma.
Chimenti S, D'Ottavio V.
J Dermatol Surg Oncol. 1984 Mar;10(3):161. No abstract available.
Isolated B-cell lymphoma of the skin.
Chimenti S, Calvieri S.
J Dermatol Surg Oncol. 1984 Apr;10(4):299-303. No abstract available.
Immunocytochemical study of a trabecular carcinoma of the skin (Merkel cell tumor). Case report.
Carlei F, Lomanto D, Chimenti S, Pranteda G, Castagna G, Lezoche E, Mariani P, D'Alessandro
MD, Gendel SE, Speranza V.
Ital J Surg Sci. 1986;16(1):55-9.
Classification of non-Hodgkin malignant lymphomas of the skin.
Ribuffo A, Chimenti S, Calvieri S, Cantoresi F, Clerico R, Bianchini D, Ribuffo M.
Int J Tissue React. 1986;8(2):135-40.
Acanthoma fissuratum.
Cerroni L, Soyer HP, Chimenti S.
J Dermatol Surg Oncol. 1988 Sep;14(9):1003-5.
Juvenile colloid milium. Immunohistochemical and ultrastructural studies.
Hashimoto K, Nakayama H, Chimenti S, Carlesimo OA, Calvieri S, Iacobelli D, Bianchi L.
J Cutan Pathol. 1989 Jun;16(3):164-74.
[Analysis of point mutations of Ha-ras gene in basaliomas and spinaliomas usiang the polymerase
chain reaction (PCR) technic].
Peris K, Cerroni L, Chimenti S, Soyer HP, Kerl H, Höfler H.
G Ital Dermatol Venereol. 1989 Oct;124(10):429-34. Italian.
[Immunophenotype of lymphocytic infiltrate in mycosis fungoides at the plaque stage and at the
tumor stage. A comparative study].
Cerroni L, Peris K, Torlone G, Chimenti S.
G Ital Dermatol Venereol. 1990 Aug;125(7-8):313-7. Italian.
Proto-oncogene expression in dermal naevi and melanomas.
Peris K, Cerroni L, Chimenti S, Soyer HP, Kerl H, Höfler H.
Arch Dermatol Res. 1991;283(8):500-5.
Expression of c-myc in cutaneous lymphomas and pseudolymphomas.
Peris K, Cerroni L, Kerl H, Radaszkiewicz T, Chimenti S, Höfler H.
Dermatologica. 1991;183(1):1-6.
Angiosarcoma of the face and scalp. A case report with complete spontaneous regression.
Cerroni L, Peris K, Legge A, Chimenti S.
J Dermatol Surg Oncol. 1991 Jun;17(6):539-42.
Detection of Epstein-Barr virus genome in primary cutaneous T and B cell lymphomas and
pseudolymphomas.
Peris K, Niedermeyer H, Cerroni L, Radaskiewicz T, Chimenti S, Höfler H.
Arch Dermatol Res. 1994;286(7):364-8.
The specific effects of 8-methoxypsoralen photoadducts on cell growth: HPLC analysis of
monoadduct and crosslink formation in cells exposed to split-dose treatment.
Schmitt IM, Maxwell VM, Olack GA, Edelson RL, Chimenti S, Gasparro FP.
J Photochem Photobiol B. 1994 Jan;22(1):17-21.
Cutaneous eyebrow metastasis in a patient with primary gastric adenocarcinoma.
Peris K, Cerroni L, D'Alessandro I, Chimenti S.
Acta Derm Venereol. 1994 Mar;74(2):154-5. No abstract available.
Gingival metastasis as first sign of an undifferentiated carcinoma of the lung.
Peris K, Cerroni L, Paoloni M, Margiotta V, Chimenti S.
J Dermatol Surg Oncol. 1994 Jun;20(6):407-9.
Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma.
Chimenti S, Peris K, Di Cristofaro S, Fargnoli MC, Torlone G.
Dermatology. 1995;190(3):214-7.
Psoralen-protein photochemistry--a forgotten field.
Schmitt IM, Chimenti S, Gasparro FP.
J Photochem Photobiol B. 1995 Feb;27(2):101-7. Review.
Keratoderma hereditarium mutilans (Vohwinkel's syndrome) associated with congenital
deafmutism.
Peris K, Salvati EF, Torlone G, Chimenti S.
Br J Dermatol. 1995 Apr;132(4):617-2.
Increased surface expression of class I MHC molecules on immunogenic cells derived from the
xenogenization of P815 mastocytoma cells with 8-methoxypsoralen and long-wavelength
ultraviolet radiation.
Schmitt IM, Moor AC, Patrignelli R, Chimenti S, Beijersbergen van Henegouwen GM, Edelson
RL, Gasparro FP.
Tissue Antigens. 1995 Jul;46(1):45-9.
Treatment with 8-MOP and UVA enhances MHC class I synthesis in RMA cells: preliminary
results.
Moor AC, Schmitt IM, Beijersbergen van Henegouwen GM, Chimenti S, Edelson RL, Gasparro FP.
J Photochem Photobiol B. 1995 Aug;29(2-3):193-8.
Microsatellite instability and loss of heterozygosity in melanoma.
Peris K, Keller G, Chimenti S, Amantea A, Kerl H, Höfler H.
J Invest Dermatol. 1995 Oct;105(4):625-8.
Detection of Epstein-Barr virus in cutaneous and lymph nodal anaplastic large cell lymphomas (Ki1+).
Peris K, Niedermeyer H, Chimenti S, Radaskiewicz T, Kerl H, Hoefler H.
Br J Dermatol. 1995 Oct;133(4):542-6.
Primary centroblastic/centrocytic lymphoma of the skin. Detection of B-cell monoclonality by
polymerase chain reaction.
Peris K, Caracciolo E, Weirich G, Chimenti S.
Am J Dermatopathol. 1995 Oct;17(5):506-10.
Penile metastases from bladder carcinoma.
Filosa G, Bugatti L, Peris K, Chimenti S.
Acta Derm Venereol. 1996 May;76(3):250-1. No abstract available.
The role of MT2 and anti-bcl-2 protein antibodies in the differentiation of benign from malignant
cutaneous infiltrates of B-lymphocytes with germinal center formation.
Chimenti S, Cerroni L, Zenahlik P, Peris K, Kerl H.
J Cutan Pathol. 1996 Aug;23(4):319-22.
Induction of functional empty class I major histocompatibility complex glycoproteins by
photoactivated 8-methoxypsoralen.
Imaeda S, Felli A, Schmitt I, Chimenti S, Edelson RL.
J Invest Dermatol. 1996 Dec;107(6):887-90.
Lymphoblastic lymphoma of the pre-B phenotype with cutaneous presentation.
Schmitt IM, Manente L, Di Matteo A, Felici F, Giangiacomi M, Chimenti S.
Dermatology. 1997;195(3):289-92.
Numerical aberrations of chromosome 7 detected in 15 microns paraffin-embedded tissue sections
of primary cutaneous melanomas by fluorescence in situ hybridization and confocal laser scanning
microscopy.
D'Alessandro I, Zitzelsberger H, Hutzler P, Lehmann L, Braselmann H, Chimenti S, Höfler H.
J Cutan Pathol. 1997 Feb;24(2):70-5.
Analysis of microsatellite instability and loss of heterozygosity in keratoacanthoma.
Peris K, Magrini F, Keller G, Manente L, D'Alessandro E, Onorati MT, Höfler H, Chimenti S.
Arch Dermatol Res. 1997 Mar;289(4):185-8.
Multiple microsatellite alterations on chromosome 9 in neurofibromas of NF-1 patients.
Fargnoli MC, Chimenti S, Peris K.
J Invest Dermatol. 1997 May;108(5):812-3. No abstract available.
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous
Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Peréz JL, Geerts ML, Goos M,
Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJ.
Blood. 1997 Jul 1;90(1):354-71. Review.
Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of
Zap70, Syk and membrane-associated Csk.
Fargnoli MC, Edelson RL, Berger CL, Chimenti S, Couture C, Mustelin T, Halaban R.
Leukemia. 1997 Aug;11(8):1338-46.
"Clown nose" as a first manifestation of lung carcinoma.
De Simoni I, Iacovelli P, Lunghi F, Peris K, Chimenti S.
Acta Derm Venereol. 1997 Sep;77(5):406-7. No abstract available.
Cutaneous epithelioid cell histiocytoma: immunohistochemical and ultrastructural findings
suggesting endothelial origin.
Manente L, Schmitt I, Onetti AM, Peris K, Caracciolo E, Chimenti S.
Am J Dermatopathol. 1997 Oct;19(5):519-23.
Widespread microsatellite instability in sebaceous tumours of patients with the Muir-Torre
syndrome.
Peris K, Onorati MT, Keller G, Magrini F, Donati P, Muscardin L, Höfler H, Chimenti S.
Br J Dermatol. 1997 Sep;137(3):356-60.
Peripheral nervous system involvement in a patient with large T-cell lymphoma arising from a
preexisting mycosis fungoides.
Peris K, Fargnoli MC, Berardelli A, Crecco M, Tomaselli R, Chimenti S.
Br J Dermatol. 1998 Aug;139(2):299-301.
CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds.
Fargnoli MC, Chimenti S, Keller G, Soyer HP, Dal Pozzo V, Höfler H, Peris K.
UV fingerprint CDKN2a but no p14ARF mutations in sporadic melanomas.
Peris K, Chimenti S, Fargnoli MC, Valeri P, Kerl H, Wolf P.
Reduced expression of CDKN2a/P16INK4a in mycosis fungoides.
Peris K, Stanta G, Fargnoli MC, Bonin S, Felli A, Amantea A, Chimenti S.
Arch Dermatol Res. 1999 Apr;291(4):207-11.
Teledermascopy: a preliminary study.
Piccolo D, Wolf IH, Peris K, Hofmann-Wellenhof R, Dell Eva G, Burroni M, Smolle J, Kerl H,
Chimenti S, Soyer PH.
Adv Clin Path. 1998 Apr;2(2):162-163. No abstract available.
The use of chemical peelings in the treatment of different cutaneous hyperpigmentations.
Cotellessa C, Peris K, Onorati MT, Fargnoli MC, Chimenti S.
Dermatol Surg. 1999 Jun;25(6):450-4.
Cutaneous involvement in lymphoblastic lymphoma.
Chimenti S, Fink-Puches R, Peris K, Pescarmona E, Pütz B, Kerl H, Cerroni L.
J Cutan Pathol. 1999 Sep;26(8):379-85.
Pilotropic mycosis fungoides.
Peris K, Chimenti S, Sacerdoti G, Muscardin L, Fazio M.
Dermatology. 1999;199(2):192-4. No abstract available.
Face-to-face diagnosis vs telediagnosis of pigmented skin tumors: a teledermoscopic study.
Piccolo D, Smolle J, Wolf IH, Peris K, Hofmann-Wellenhof R, Dell'Eva G, Burroni M, Chimenti S,
Kerl H, Soyer HP.
Arch Dermatol. 1999 Dec;135(12):1467-71.
Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma.
Peris K, Fargnoli MC, Chimenti S.
N Engl J Med. 1999 Dec 2;341(23):1767-8. No abstract available.
Teledermoscopy--results of a multicentre study on 43 pigmented skin lesions.
Piccolo D, Smolle J, Argenziano G, Wolf IH, Braun R, Cerroni L, Ferrari A, Hofmann-Wellenhof
R, Kenet RO, Magrini F, Mazzocchetti G, Pizzichetta MA, Schaeppi H, Stolz W, Tanaka M, Kerl
H, Chimenti S, Soyer HP.
J Telemed Telecare. 2000;6(3):132-7.
Dermoscopic features of cutaneous local recurrent melanoma.
Ferrari A, Peris K, Piccolo D, Chimenti S.
J Am Acad Dermatol. 2000 Oct;43(4):722-4.
Central white scarlike patch: a dermatoscopic clue for the diagnosis of dermatofibroma.
Ferrari A, Soyer HP, Peris K, Argenziano G, Mazzocchetti G, Piccolo D, De Giorgi V, Chimenti S.
J Am Acad Dermatol. 2000 Dec;43(6):1123-5.
The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
Cotellessa C, Peris K, Caracciolo E, Mordenti C, Chimenti S.
J Am Acad Dermatol. 2001 Jan;44(1):73-6.
Mucosal involvement in a patient with lymphomatoid papulosis.
Chimenti S, Fargnoli MC, Pacifico A, Peris K.
J Am Acad Dermatol. 2001 Feb;44(2 Suppl):339-41.
A nodule on the forearm of a patient with Hodgkin disease.
Fargnoli MC, Peris K, Cerroni L, Piccolo D, Chimenti S.
Arch Dermatol. 2001 Jan;137(1):85-90. No abstract available.
Zosteriform metastasis of occult bronchogenic carcinoma.
Bianchi L, Orlandi A, Carboni I, Costanzo A, Chimenti S.
Acta Derm Venereol. 2000 Sep-Oct;80(5):391-2. No abstract available.
Histopathologic interobserver agreement on the diagnosis of melanocytic skin lesions with
equivocal dermoscopic features: a pilot study.
Ferrara G, Argenziano G, Soyer HP, D'Argenio P, Carli P, Cerroni L, Chimenti S, De Giorgi V,
Delfino M, De Rosa G, El Shabrawi-Caelen L, Ferrari A, Massi D, Mazzocchetti G, Peris K,
Piccolo D, Santucci M, Scalvenzi M, Staibano S.
Tumori. 2000 Nov-Dec;86(6):445-9.
Differentiation between pigmented Spitz naevus and melanoma by digital dermoscopy and stepwise
logistic discriminant analysis.
Rubegni P, Ferrari A, Cevenini G, Piccolo D, Burroni M, Perotti R, Peris K, Taddeucci P, Biagioli
M, Dell'Eva G, Chimenti S, Andreassi L.
Melanoma Res. 2001 Feb;11(1):37-44.
Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21.
Capon F, Semprini S, Chimenti S, Fabrizi G, Zambruno G, Murgia S, Carcassi C, Fazio M,
Mingarelli R, Dallapiccola B, Novelli G.
J Invest Dermatol. 2001 May;116(5):728-30.
Dermoscopy of pigmented skin lesions.
Soyer HP, Argenziano G, Chimenti S, Ruocco V.
Eur J Dermatol. 2001 May-Jun;11(3):270-6; quiz 277. Review.
Unusually large cutaneous metastases of renal cell carcinoma.
Peris K, Fargnoli MC, Lunghi F, Chimenti S.
Acta Derm Venereol. 2001 Jan-Feb;81(1):77-8. No abstract available.
Pyoderma vegetans and ulcerative colitis.
Bianchi L, Carrozzo AM, Orlandi A, Campione E, Hagman JH, Chimenti S.
Br J Dermatol. 2001 Jun;144(6):1224-7.
Dermoscopy of pigmented skin lesions (Part II).
Soyer HP, Argenziano G, Ruocco V, Chimenti S.
Eur J Dermatol. 2001 Sep-Oct;11(5):483-98. Review. No abstract available.
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a
chimeric anti-CD20 monoclonal antibody.
Soda R, Costanzo A, Cantonetti M, Orlandi A, Bianchi L, Chimenti S.
Acta Derm Venereol. 2001 Jun-Jul;81(3):207-8. No abstract available.
Dermatomyositis associated with ovarian transitional cell carcinoma.
Hagman JH, Bianchi L, Campione E, Vidolin AP, Chimenti S.
J Am Acad Dermatol. 2001 Oct;45(4):642-4. No abstract available.
Is dermoscopy useful for the diagnosis of melanoma?
Soyer HP, Argenziano G, Talamini R, Chimenti S.
Arch Dermatol. 2001 Oct;137(10):1361-3. No abstract available.
Graham Little-Piccardi-Lassueur syndrome: effective treatment with cyclosporin A.
Bianchi L, Paro Vidolin A, Piemonte P, Carboni I, Chimenti S.
Clin Exp Dermatol. 2001 Sep;26(6):518-20.
Superficial black network: an additional dermoscopic clue for the diagnosis of pigmented spindle
and/or epithelioid cell nevus.
Argenziano G, Soyer HP, Ferrara G, Piccolo D, Hofmann-Wellenhof R, Peris K, Staibano S,
Chimenti S.
Dermatology. 2001;203(4):333-5.
Concordance between telepathologic diagnosis and conventional histopathologic diagnosis: a
multiobserver store-and-forward study on 20 skin specimens.
Piccolo D, Soyer HP, Burgdorf W, Talamini R, Peris K, Bugatti L, Canzonieri V, Cerroni L,
Chimenti S, De Rosa G, Filosa G, Hoffmann R, Julis I, Kutzner H, Manente L, Misciali C,
Schaeppi H, Tanaka M, Tyler W, Zelger B, Kerl H.
Arch Dermatol. 2002 Jan;138(1):53-8.
Metastatic Crohn's disease of the forehead.
Biancone L, Geboes K, Spagnoli LG, Del Vecchio Blanco G, Monteleone I, Vavassori P, Palmieri
G, Chimenti S, Pallone F.
Inflamm Bowel Dis. 2002 Mar;8(2):101-5.
Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expressions of autoimmune
polyglandular syndrome type I.
Carboni I, Soda R, Bianchi L, Chimenti S.
Acta Derm Venereol. 2002;82(1):68-9. No abstract available.
Impact of dermoscopy on the clinical management of pigmented skin lesions.
Argenziano G, Soyer HP, Chimenti S, Argenziano G, Ruocco V.
Clin Dermatol. 2002 May-Jun;20(3):200-2. Review. No abstract available.
Dermoscopic classification of Spitz/Reed nevi.
Peris K, Ferrari A, Argenziano G, Soyer HP, Chimenti S.
Clin Dermatol. 2002 May-Jun;20(3):259-62. Review. No abstract available.
Interobserver agreement on dermoscopic features of pigmented basal cell carcinoma.
Peris K, Altobelli E, Ferrari A, Fargnoli MC, Piccolo D, Esposito M, Chimenti S.
Dermatol Surg. 2002 Jul;28(7):643-5.
The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum.
Hagman JH, Carrozzo AM, Campione E, Romanelli P, Chimenti S.
J Dermatolog Treat. 2001 Mar;12(1):19-22.
Dermoscopic diagnosis by a trained clinician vs. a clinician with minimal dermoscopy training vs.
computer-aided diagnosis of 341 pigmented skin lesions: a comparative study.
Piccolo D, Ferrari A, Peris K, Diadone R, Ruggeri B, Chimenti S.
Br J Dermatol. 2002 Sep;147(3):481-6.
Dermoscopic and histopathologic diagnosis of equivocal melanocytic skin lesions: an
interdisciplinary study on 107 cases.
Ferrara G, Argenziano G, Soyer HP, Corona R, Sera F, Brunetti B, Cerroni L, Chimenti S, El
Shabrawi-Caelen L, Ferrari A, Hofmann-Wellenhof R, Kaddu S, Piccolo D, Scalvenzi M, Staibano
S, Wolf IH, De Rosa G.
Cancer. 2002 Sep 1;95(5):1094-100.
Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous
Tcell lymphoma.
Pagnanelli G, Bianchi L, Cantonetti M, Orlandi A, Fargnoli MC, Muscardin LM, Chimenti S.
Sentinel lymphadenectomy in cutaneous melanoma.
Buonomo O, Felici A, Granai AV, Piccirillo R, De Liguori Carino N, Guadagni F, Mariotti S,
Orlandi A, Tipaldi G, Cipriani C, Chimenti S, Cervelli V, Casciani CU, Roselli M.
Tumori. 2002 May-Jun;88(3):S49-51.
Granulomatous mycosis fungoides responsive to gemcitabine.
Fargnoli MC, Peris K, Francesconi F, Cantonetti M, Cerroni L, Chimenti S.
Eur J Dermatol. 2002 Sep-Oct;12(5):479-81.
Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian
population.
Borgiani P, Vallo L, D'Apice MR, Giardina E, Pucci S, Capon F, Nisticò S, Chimenti S, Pallone F,
Novelli G.
Eur J Dermatol. 2002 Nov-Dec;12(6):540-2.
Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage
colony-stimulating factor.
Bianchi L, Ginebri A, Hagman JH, Francesconi F, Carboni I, Chimenti S.
J Eur Acad Dermatol Venereol. 2002 Nov;16(6):595-8.
Molecular basis of basal cell carcinoma: analysis of differential gene expression by differential
display PCR and expression array.
Welss T, Papoutsaki M, Michel G, Reifenberger J, Chimenti S, Ruzicka T, Abts HF.
Int J Cancer. 2003 Mar 10;104(1):66-72.
Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter
retrospective analysis of 48 consecutive cases.
Prins C, Kerdel FA, Padilla RS, Hunziker T, Chimenti S, Viard I, Mauri DN, Flynn K, Trent J,
Margolis DJ, Saurat JH, French LE; TEN-IVIG Study Group. Toxic epidermal necrolysis
intravenous immunoglobulin.
Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task
Force Workshop.
Santucci M, Pimpinelli N, Massi D, Kadin ME, Meijer CJ, Müller-Hermelink HK, Paulli M,
Wechsler J, Willemze R, Audring H, Bernengo MG, Cerroni L, Chimenti S, Chott A, Díaz-Pérez
JL, Dippel E, Duncan LM, Feller AC, Geerts ML, Hallermann C, Kempf W, Russell-Jones R,
Sander C, Berti E; EORTC Cutaneous Lymphoma Task Force.
Cancer. 2003 Feb 1;97(3):610-27.
Basosquamous cell carcinoma with massive cranial osteolysis.
Bianchi L, Bernardi G, Orlandi A, Chimenti S.
Clin Exp Dermatol. 2003 Jan;28(1):96-7. No abstract available.
Efficacy evaluation of an oil-in-water emulsion (Dermoflan) in atopic dermatitis.
Peris K, Valeri P, Altobelli E, Fargnoli MC, Carrozzo AM, Chimenti S.
Microabrasion versus microabrasion followed by 15% trichloroacetic acid for treatment of
cutaneous hyperpigmentations in adult females.
Cotellessa C, Peris K, Fargnoli MC, Mordenti C, Giacomello RS, Chimenti S.
Dermatol Surg. 2003 Apr;29(4):352-6; discussion 356.
Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet.
Argenziano G, Soyer HP, Chimenti S, Talamini R, Corona R, Sera F, Binder M, Cerroni L, De
Rosa G, Ferrara G, Hofmann-Wellenhof R, Landthaler M, Menzies SW, Pehamberger H, Piccolo D,
Rabinovitz HS, Schiffner R, Staibano S, Stolz W, Bartenjev I, Blum A, Braun R, Cabo H, Carli P,
De Giorgi V, Fleming MG, Grichnik JM, Grin CM, Halpern AC, Johr R, Katz B, Kenet RO, Kittler
H, Kreusch J, Malvehy J, Mazzocchetti G, Oliviero M, Ozdemir F, Peris K, Perotti R, Perusquia A,
Pizzichetta MA, Puig S, Rao B, Rubegni P, Saida T, Scalvenzi M, Seidenari S, Stanganelli I,
Tanaka M, Westerhoff K, Wolf IH, Braun-Falco O, Kerl H, Nishikawa T, Wolff K, Kopf AW.
J Am Acad Dermatol. 2003 May;48(5):679-93.
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic
performance of non-experts.
Pagnanelli G, Soyer HP, Argenziano G, Talamini R, Barbati R, Bianchi L, Campione E, Carboni I,
Carrozzo AM, Chimenti MS, de Simoni I, Falcomatà V, Filipe Neto I, Francesconi F, Ginebri A,
Hagman J, Marulli GC, Palamara F, Vidolin AP, Piemonte P, Soda R, Chimenti S.
Br J Dermatol. 2003 Apr;148(4):698-702.
Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient
infected by human immunodeficiency virus.
Hagman JH, Bianchi L, Marulli GC, Soda R, Chimenti S.
Clin Exp Dermatol. 2003 May;28(3):260-1.
Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study.
Bianchi L, Soda R, Diluvio L, Chimenti S.
Br J Dermatol. 2003 Jul;149(1):207-9. No abstract available.
Treatment of occupational koilonychia with tazarotene gel.
Hagman JH, Ginebri A, Mordenti C, De Simoni I, Chimenti S.
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of
seven patients.
Bianchi L, Costanzo A, Campione E, Nisticò S, Chimenti S.
Clin Exp Dermatol. 2003 Nov;28 Suppl 1:24-6.
Actinic keratosis treated with an immune response modifier: a case report of six patients.
Bianchi L, Campione E, Marulli GC, Costanzo A, Chimenti S.
Clin Exp Dermatol. 2003 Nov;28 Suppl 1:39-41.
A 2-year history of an asymptomatic scalp nodule.
Soda R, Vidolin AP, Bianchi L, Chimenti S.
Arch Dermatol. 2003 Nov;139(11):1497-502. No abstract available.
Coexpression of bone sialoprotein (BSP) and the pivotal transcriptional regulator of osteogenesis,
Cbfa1/Runx2, in malignant melanoma.
Riminucci M, Corsi A, Peris K, Fisher LW, Chimenti S, Bianco P.
Calcif Tissue Int. 2003 Sep;73(3):281-9.
Jumping into the future using teledermoscopy.
Piccolo D, Peris K, Chimenti S, Argenziano G, Soyer HP.
Skinmed. 2002 Sep-Oct;1(1):20-4.
Melanocytic nevi of the breast: a histologic case-control study.
Rongioletti F, Urso C, Batolo D, Chimenti S, Fanti PA, Filotico R, Gianotti R, Innocenzi D, Lentini
M, Tomasini C, Pippione M, Rebora A.
J Cutan Pathol. 2004 Feb;31(2):137-40.
Treatment of lentigo maligna with tazarotene 0.1% gel.
Chimenti S, Carrozzo AM, Citarella L, De Felice C, Peris K.
J Am Acad Dermatol. 2004 Jan;50(1):101-3.
Three-point checklist of dermoscopy. A new screening method for early detection of melanoma.
Soyer HP, Argenziano G, Zalaudek I, Corona R, Sera F, Talamini R, Barbato F, Baroni A, Cicale L,
Di Stefani A, Farro P, Rossiello L, Ruocco E, Chimenti S.
Dermatology. 2004;208(1):27-31.
Fumaric acid esters in the treatment of psoriasis: an Italian experience.
Carboni I, De Felice C, De Simoni I, Soda R, Chimenti S.
J Dermatolog Treat. 2004 Jan;15(1):23-6.
Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean
population.
Fargnoli MC, Chimenti S, Keller G, Höfler H, Peris K.
Hum Mutat. 2003 Jun;21(6):655.
Treatment of vitiligo with the 308 nm excimer laser.
Esposito M, Soda R, Costanzo A, Chimenti S.
Clin Exp Dermatol. 2004 Mar;29(2):133-7.
Constitutional and environmental risk factors for cutaneous melanoma in an Italian population. A
case-control study.
Fargnoli MC, Piccolo D, Altobelli E, Formicone F, Chimenti S, Peris K.
Melanoma Res. 2004 Apr;14(2):151-7.
A new insight into our understanding of neurofibromatosis type 1?
Chimenti S.
J Eur Acad Dermatol Venereol. 2004 May;18(3):261. No abstract available.
Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with
tazarotene.
Orlandi A, Bianchi L, Costanzo A, Campione E, Giusto Spagnoli L, Chimenti S.
J Invest Dermatol. 2004 Apr;122(4):1037-41.
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian
population.
Giardina E, Novelli G, Costanzo A, Nisticò S, Bulli C, Sinibaldi C, Sorgi ML, Chimenti S, Pallone
F, Taccari E, Borgiani P.
J Invest Dermatol. 2004 May;122(5):1106-7.
CDKN2A and MC1R mutations in patients with sporadic multiple primary melanoma.
Peris K, Fargnoli MC, Pacifico A, Surrenti T, Stolz W, Wolf P, Soyer HP, Chimenti S.
Ink spot lentigo arising on naevus spilus simulating melanoma.
Marulli GC, Campione E, Di Stefani A, Citarella L, Chimenti S.
Biological therapies in the systemic management of psoriasis: International Consensus Conference.
Sterry W, Barker J, Boehncke WH, Bos JD, Chimenti S, Christophers E, De La Brassinne M,
Ferrandiz C, Griffiths C, Katsambas A, Kragballe K, Lynde C, Menter A, Ortonne JP, Papp K,
Prinz J, Rzany B, Ronnevig J, Saurat JH, Stahle M, Stengel FM, Van De Kerkhof P, Voorhees J.
Br J Dermatol. 2004 Aug;151 Suppl 69:3-17. Review.
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large
series of cases.
Bianchi L, Orlandi A, Campione E, Angeloni C, Costanzo A, Spagnoli LG, Chimenti S.
Br J Dermatol. 2004 Jul;151(1):148-56.
Psoriasis, Kaposi's sarcoma and Hodgkin's disease in a patient with Down's syndrome.
Fargnoli MC, Peris K, Frascione P, Barbati R, Anemona L, Uccini S, Francesconi F, Chimenti S.
Dermatology. 2004;209(2):158-9. No abstract available.
Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis
fungoides.
Nisticò S, Costanzo A, Saraceno R, Chimenti S.
Br J Dermatol. 2004 Oct;151(4):877-9.
Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis
susceptibility locus.
Giardina E, Capon F, De Rosa MC, Mango R, Zambruno G, Orecchia A, Chimenti S, Giardina B,
Novelli G.
Ann Hum Genet. 2004 Nov;68(Pt 6):639-45.
Diagnosis and categorization of acral melanocytic lesions using teledermoscopy.
Piccolo D, Soyer HP, Chimenti S, Argenziano G, Bartenjev I, Hofmann-Wellenhof R, Marchetti R,
Oguchi S, Pagnanelli G, Pizzichetta MA, Saida T, Salvemini I, Tanaka M, Wolf IH, Zgavec B,
Peris K.
J Telemed Telecare. 2004;10(6):346-50.
The p73 gene is an anti-tumoral target of the RARbeta/gamma-selective retinoid tazarotene.
Papoutsaki M, Lanza M, Marinari B, Nisticò S, Moretti F, Levrero M, Chimenti S, Costanzo A.
Safety and efficacy study on etanercept in patients with plaque psoriasis.
Costanzo A, Mazzotta A, Papoutsaki M, Nisticò S, Chimenti S.
Br J Dermatol. 2005 Jan;152(1):187-9. No abstract available.
A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemiareperfusion
injury.
Fiordaliso F, Chimenti S, Staszewsky L, Bai A, Carlo E, Cuccovillo I, Doni M, Mengozzi M,
Tonelli R, Ghezzi P, Coleman T, Brines M, Cerami A, Latini R.
Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2046-51. Epub 2005 Jan 25.
WHO-EORTC classification for cutaneous lymphomas.
Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, DiazPerez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli
N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ.
Blood. 2005 May 15;105(10):3768-85. Epub 2005 Feb 3. Review.
Teledermatology: just cool or a real tool?
Burg G, Hasse U, Cipolat C, Kropf R, Djamei V, Soyer HP, Chimenti S.
Dermatology. 2005;210(2):169-73. Review.
Dermoscopic monitoring of tazarotene treatment of superficial basal cell carcinoma.
Peris K, Ferrari A, Fargnoli MC, Piccolo D, Chimenti S.
Dermatol Surg. 2005 Feb;31(2):217-20. No abstract available.
Histological features used in the diagnosis of melanoma are frequently found in benign melanocytic
naevi.
Urso C, Rongioletti F, Innocenzi D, Batolo D, Chimenti S, Fanti PL, Filotico R, Gianotti R, Lentini
M, Tomasini C, Pippione M.
J Clin Pathol. 2005 Apr;58(4):409-12.
Remission and time of resolution of nail psoriasis during infliximab therapy.
Bianchi L, Bergamin A, de Felice C, Capriotti E, Chimenti S.
J Am Acad Dermatol. 2005 Apr;52(4):736-7. No abstract available.
Treatment of trachyonychia with tazarotene.
Soda R, Diluvio L, Bianchi L, Chimenti S.
Clin Exp Dermatol. 2005 May;30(3):301-2. No abstract available.
Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial.
Peris K, Campione E, Micantonio T, Marulli GC, Fargnoli MC, Chimenti S.
Dermatol Surg. 2005 Mar;31(3):318-23.
Fate of UVB-induced p53 mutations in SKH-hr1 mouse skin after discontinuation of irradiation:
relationship to skin cancer development.
Melnikova VO, Pacifico A, Chimenti S, Peris K, Ananthaswamy HN.
Oncogene. 2005 Oct 27;24(47):7055-63.
A p38-dependent pathway regulates DeltaNp63 DNA binding to p53-dependent promoters in
UVinduced apoptosis of keratinocytes.
Papoutsaki M, Moretti F, Lanza M, Marinari B, Sartorelli V, Guerrini L, Chimenti S, Levrero M,
Costanzo A.
Oncogene. 2005 Oct 20;24(46):6970-5.
Interobserver reproducibility of histological features in cutaneous malignant melanoma.
Urso C, Rongioletti F, Innocenzi D, Saieva C, Batolo D, Chimenti S, Filotico R, Gianotti R, Lentini
M, Tomasini C, Rebora A, Pippione M.
J Clin Pathol. 2005 Nov;58(11):1194-8.
Topical use of calcitriol 3 microg/g ointment in the treatment of mild-to-moderate psoriasis: results
from an open-label study.
Carboni I, de Felice C, Bergamin A, Chimenti S.
J Eur Acad Dermatol Venereol. 2005 Nov;19 Suppl 3:11-3.
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects.
Burg G, Kempf W, Cozzio A, Feit J, Willemze R, S Jaffe E, Dummer R, Berti E, Cerroni L,
Chimenti S, Diaz-Perez JL, Grange F, Harris NL, Kazakov DV, Kerl H, Kurrer M, Knobler R,
Meijer CJ, Pimpinelli N, Ralfkiaer E, Russell-Jones R, Sander C, Santucci M, Sterry W, Swerdlow
SH, Vermeer MH, Wechsler J, Whittaker S.
J Cutan Pathol. 2005 Nov;32(10):647-74. Review.
The spectrum of Spitz nevi: a clinicopathologic study of 83 cases.
Ferrara G, Argenziano G, Soyer HP, Chimenti S, Di Blasi A, Pellacani G, Peris K, Piccolo D,
Rubegni P, Seidenari S, Staibano S, Zalaudek I, De Rosa G.
Arch Dermatol. 2005 Nov;141(11):1381-7.
Etanercept for the treatment of severe childhood psoriasis.
Papoutsaki M, Costanzo A, Mazzotta A, Gramiccia T, Soda R, Chimenti S.
Br J Dermatol. 2006 Jan;154(1):181-3. No abstract available.
VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells.
Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Jung S, Chimenti S, Landsman L,
Abramovitch R, Keshet E.
Cell. 2006 Jan 13;124(1):175-89. Erratum in: Cell. 2006 Aug 25;126(4):811.
Re: MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean
population.
Fargnoli MC, Spica T, Sera F, Pellacani G, Chiarugi A, Seidenari S, Carli P, Chimenti S, Peris K.
J Natl Cancer Inst. 2006 Jan 18;98(2):144-5; author reply 145-6. No abstract available.
An Italian study on psoriasis and depression.
Esposito M, Saraceno R, Giunta A, Maccarone M, Chimenti S.
Dermatology. 2006;212(2):123-7.
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous
Lymphomas.
Zinzani PL, Quaglino P, Pimpinelli N, Berti E, Baliva G, Rupoli S, Martelli M, Alaibac M, Borroni
G, Chimenti S, Alterini R, Alinari L, Fierro MT, Cappello N, Pileri A, Soligo D, Paulli M, Pileri S,
Santucci M, Bernengo MG; Italian Study Group for Cutaneous Lymphomas.
J Clin Oncol. 2006 Mar 20;24(9):1376-82. Epub 2006 Feb 21.
Short contact therapy with tazarotene in psoriasis vulgaris.
Veraldi S, Caputo R, Pacifico A, Peris K, Soda R, Chimenti S.
Dermatology. 2006;212(3):235-7.
Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a
population in central Italy: a case-control study.
Fargnoli MC, Altobelli E, Keller G, Chimenti S, Höfler H, Peris K.
Melanoma Res. 2006 Apr;16(2):175-82.
Long-lasting remission of pemphigus vulgaris treated with rituximab.
Esposito M, Capriotti E, Giunta A, Bianchi L, Chimenti S.
A 308-nm monochromatic excimer light in the treatment of palmoplantar psoriasis.
Nisticò SP, Saraceno R, Stefanescu S, Chimenti S.
J Eur Acad Dermatol Venereol. 2006 May;20(5):523-6.
Identical TCR beta-chain rearrangements in streptococcal angina and skin lesions of patients with
psoriasis vulgaris.
Diluvio L, Vollmer S, Besgen P, Ellwart JW, Chimenti S, Prinz JC.
J Immunol. 2006 Jun 1;176(11):7104-11.
Severe acne successfully treated with etanercept.
Campione E, Mazzotta AM, Bianchi L, Chimenti S.
PSORS2 markers are not associated with psoriatic arthritis in the Italian population.
Giardina E, Predazzi I, Sinibaldi C, Peconi C, Amerio P, Costanzo A, Paradisi A, Capizzi R,
Paradisi M, Chimenti S, Taccari E, Novelli G.
Hum Hered. 2006;61(2):120-2. Epub 2006 May 30.
"Familial" generalized argyria.
Bianchi L, Orlandi A, Di Stefani A, Ricci R, Chimenti S.
Arch Dermatol. 2006 Jun;142(6):789-90. No abstract available.
Treatment of erythrodermic psoriasis with etanercept.
Esposito M, Mazzotta A, de Felice C, Papoutsaki M, Chimenti S.
Br J Dermatol. 2006 Jul;155(1):156-9.
Clinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with
moderate-to-severe plaque psoriasis: results from a phase III international randomized,
placebocontrolled trial.
Dubertret L, Sterry W, Bos JD, Chimenti S, Shumack S, Larsen CG, Shear NH, Papp KA; CLEAR
Multinational Study Group.
Br J Dermatol. 2006 Jul;155(1):170-81.
Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma.
Peris K, Micantonio T, Fargnoli MC, Lozzi GP, Chimenti S.
J Am Acad Dermatol. 2006 Aug;55(2):324-7.
Co-localization of susceptibility loci for psoriasis (PSORS4) and atopic dermatitis (ATOD2) on
human chromosome 1q21.
Giardina E, Sinibaldi C, Chini L, Moschese V, Marulli G, Provini A, Rossi P, Paradisi M, Chimenti
S, Galli E, Brunetti E, Girolomoni G, Novelli G.
Hum Hered. 2006;61(4):229-36. Epub 2006 Aug 15.
Recommendations for the use of etanercept in psoriasis: a European dermatology expert group
consensus.
Boehncke WH, Brasie RA, Barker J, Chimenti S, Daudén E, de Rie M, Dubertret L, Giannetti A,
Katsambas A, Kragballe K, Naeyaert JM, Ortonne JP, Peyrí J, Prinz JC, Saurat JH, Strohal R, van
de Kerkhof P, Sterry W; European Dermatology Expert Group.
J Eur Acad Dermatol Venereol. 2006 Sep;20(8):988-98.
Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53
gain-of-function mutants.
Lanza M, Marinari B, Papoutsaki M, Giustizieri ML, D'Alessandra Y, Chimenti S, Guerrini L,
Costanzo A.
Cell Cycle. 2006 Sep;5(17):1996-2004. Epub 2006 Sep 1.
European patient perspectives on the impact of psoriasis: the EUROPSO patient membership
survey.
Dubertret L, Mrowietz U, Ranki A, van de Kerkhof PC, Chimenti S, Lotti T, Schäfer G; EUROPSO
Patient Survey Group.
Br J Dermatol. 2006 Oct;155(4):729-36.
CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous
Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer.
Assaf C, Gellrich S, Whittaker S, Robson A, Cerroni L, Massone C, Kerl H, Rose C, Chott A,
Chimenti S, Hallermann C, Petrella T, Wechsler J, Bagot M, Hummel M, Bullani-Kerl K, Bekkenk
MW, Kempf W, Meijer CJ, Willemze R, Sterry W.
J Clin Pathol. 2007 Sep;60(9):981-9. Epub 2006 Oct 3.
Hypoepiluminescence microscopy of pigmented skin lesions: new approach to improve recognition
of dermoscopic structures.
Piccolo D, Fargnoli MC, Ferrara G, Lozzi GP, Altamura D, Ventura T, Chimenti S, Peris K.
Dermatol Surg. 2006 Nov;32(11):1391-7.
Green sweating spots on hands and feet: unusual expression of hyperbilirubinemia.
Di Stefani A, Bianchi L, Orlandi A, Chimenti S.
Ann Intern Med. 2006 Nov 7;145(9):710-1. No abstract available.
Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy.
Centofanti M, Oddone F, Chimenti S, Tanga L, Citarella L, Manni G.
Am J Ophthalmol. 2006 Dec;142(6):1059-60. Epub 2006 Aug 7.
Staphylococcal Scalded Skin Syndrome: Criteria for Differential Diagnosis from Lyell's Syndrome.
Two Cases in Adult Patients.
Napoli B, D'Arpa N, D'Amelio L, Chimenti S, Pileri D, Accardo-Palumbo A, Conte F.
Ann Burns Fire Disasters. 2006 Dec 31;19(4):188-91.
A classification of psoriasis vulgaris according to phenotype.
Griffiths CE, Christophers E, Barker JN, Chalmers RJ, Chimenti S, Krueger GG, Leonardi C,
Menter A, Ortonne JP, Fry L.
Br J Dermatol. 2007 Feb;156(2):258-62.
Ichthyosiform mycosis fungoides: a neoplastic acquired ichthyosis.
Bianchi L, Papoutsaki M, Orlandi A, Citarella L, Chimenti S.
Long-term treatment of plaque psoriasis with efalizumab: an Italian experience.
Costanzo A, Peris K, Talamonti M, Di Cesare A, Fargnoli MC, Botti E, Chimenti S.
Br J Dermatol. 2007 Apr;156 Suppl 2:17-23.
Analysis of health care and actual needs of patients with psoriasis: a survey on the Italian
population.
Altobelli E, Maccarone M, Petrocelli R, Marziliano C, Giannetti A, Peris K, Chimenti S.
BMC Public Health. 2007 Apr 21;7:59.
Cerebral cavernomas in a family with multiple cutaneous and uterine leiomyomas associated with a
new mutation in the fumarate hydratase gene.
Campione E, Terrinoni A, Orlandi A, Codispoti A, Melino G, Bianchi L, Mazzotta A, Garaci FG,
Ludovici A, Chimenti S.
J Invest Dermatol. 2007 Sep;127(9):2271-3. Epub 2007 May 3. No abstract available.
Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp
psoriasis.
Mazzotta A, Esposito M, Carboni I, Schipani C, Chimenti S.
J Dermatolog Treat. 2007;18(2):84-7.
Family history of psoriasis and age at disease onset in Italian patients with psoriasis.
Altobelli E, Petrocelli R, Marziliano C, Fargnoli MC, Maccarone M, Chimenti S, Peris K.
Br J Dermatol. 2007 Jun;156(6):1400-1. No abstract available.
Childhood nail psoriasis: a useful treatment with tazarotene 0.05%.
Diluvio L, Campione E, Paternò EJ, Mordenti C, El Hachem M, Chimenti S.
Pediatr Dermatol. 2007 May-Jun;24(3):332-3.
Feasibility of a two-step teledermatologic approach for the management of patients with multiple
pigmented skin lesions.
Di Stefani A, Zalaudek I, Argenziano G, Chimenti S, Soyer HP.
Dermatol Surg. 2007 Jun;33(6):686-92.
Consecutive use of different biological therapies in the treatment of psoriasis.
Costanzo A, Papoutsaki M, Mazzotta A, Chimenti S.
Br J Dermatol. 2007 Aug;157(2):394. Epub 2007 Jun 6. No abstract available.
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients
previously treated with other biologics.
Papoutsaki M, Chimenti MS, Costanzo A, Talamonti M, Zangrilli A, Giunta A, Bianchi L,
Chimenti S.
J Am Acad Dermatol. 2007 Aug;57(2):269-75. Epub 2007 Jun 18.
Effectiveness of imiquimod on Molluscum contagiosum viral chemokines.
Campione E, Peris K, Paternò EJ, Chimenti S.
J Cutan Med Surg. 2007 Jul-Aug;11(4):156-8.
High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: efficacy, safety and
impact on patients' quality of life.
De Felice C, Mazzotta A, Esposito M, Bianchi L, Chimenti S.
Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study.
Finzi A, Colombo D, Caputo A, Andreassi L, Chimenti S, Vena G, Simoni L, Sgarbi S, Giannetti
A; PSYCHAE Study Group.
J Eur Acad Dermatol Venereol. 2007 Oct;21(9):1161-9.
Phrynoderma: a cutaneous sign of an inadequate diet.
Di Stefani A, Orlandi A, Chimenti S, Bianchi L.
CMAJ. 2007 Oct 9;177(8):855-6. No abstract available.
Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus
calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical
trial.
Saraceno R, Andreassi L, Ayala F, Bongiorno MR, Giannetti A, Lisi P, Martini P, Peris K, Peserico
A, Chimenti S.
Erysipeloid cutaneous metastasis from bladder carcinoma.
Zangrilli A, Saraceno R, Sarmati L, Orlandi A, Bianchi L, Chimenti S.
Eur J Dermatol. 2007 Nov-Dec;17(6):534-6. Epub 2007 Oct 19.
A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan
therapy.
Saraceno R, Citarella L, Spallone G, Chimenti S.
Clin Exp Dermatol. 2008 Mar;33(2):154-5. Epub 2007 Nov 16.
Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers.
Pacifico A, Goldberg LH, Peris K, Chimenti S, Leone G, Ananthaswamy HN.
Br J Dermatol. 2008 Feb;158(2):291-7. Epub 2007 Dec 6. Erratum in: Br J Dermatol. 2008
Mar;158(3):657.
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with
chronic hepatitis B.
Campione E, Paternò EJ, Diluvio L, Bianchi L, Giorgetti G, Chimenti S.
Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximab.
Ruzzetti M, Saraceno R, Carboni I, Papoutsaki M, Chimenti S.
J Eur Acad Dermatol Venereol. 2008 Jan;22(1):117-8. No abstract available.
Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis.
Saraceno R, Nisticò SP, Capriotti E, de Felice C, Rhodes LE, Chimenti S.
Photodermatol Photoimmunol Photomed. 2008 Feb;24(1):43-5.
Recent patents and new strategies in the treatment of psoriasis.
Saraceno R, Di Stefani A, Giunta A, Chimenti S.
Recent Pat Antiinfect Drug Discov. 2006 Nov;1(3):353-64.
Efficacy of monochromatic excimer light (308 nm) in the treatment of atopic dermatitis in adults
and children.
Nisticò SP, Saraceno R, Capriotti E, Felice CD, Chimenti S.
Photomed Laser Surg. 2008 Feb;26(1):14-8.
Regional distribution of psoriasis in Italy.
Saraceno R, Mannheimer R, Chimenti S.
J Eur Acad Dermatol Venereol. 2008 Mar;22(3):324-9.
Etanercept at different dosages in the treatment of generalized pustular psoriasis: a case series.
Esposito M, Mazzotta A, Casciello C, Chimenti S.
Dermatology. 2008;216(4):355-60. Epub 2008 Feb 20.
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis.
Papoutsaki M, Costanzo A, Chimenti MS, Chimenti S.
Expert Opin Biol Ther. 2008 Mar;8(3):363-70. Review.
Long-term efficacy of etanercept in hidradenitis suppurativa.
Zangrilli A, Esposito M, Mio G, Mazzotta A, Chimenti S.
J Eur Acad Dermatol Venereol. 2008 Nov;22(10):1260-2. Epub 2008 Mar 7. No abstract available.
Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis.
Saraceno R, Schipani C, Mazzotta A, Esposito M, Di Renzo L, De Lorenzo A, Chimenti S.
Pharmacol Res. 2008 Apr;57(4):290-5. Epub 2008 Feb 29.
Acute onset disseminated superficial porokeratosis heralding diffuse large B-cell lymphoma.
Diluvio L, Campione E, Paterno EJ, Hagman JH, Anemona L, Orlandi A, Chimenti S.
Eur J Dermatol. 2008 May-Jun;18(3):349-50. Epub 2008 May 13. No abstract available.
Therapeutic options in an immunocompromised patient with pemphigus vulgaris: potential interest
of plasmapheresis and extracorporeal photochemotherapy.
Saraceno R, Ruzzetti M, Lanti A, Marinacci M, Chimenti S.
Eur J Dermatol. 2008 May-Jun;18(3):354-6. Epub 2008 May 13. No abstract available.
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis.
Esposito M, Saraceno R, Schipani C, Di Marcantonio D, Bianchi L, Chimenti S.
J Infect. 2008 Jul;57(1):90-2. Epub 2008 May 21. No abstract available.
How to manage infections in the era of biologics?
Saraceno R, Chimenti S.
Dermatol Ther. 2008 May-Jun;21(3):180-6. Review.
Long-term efficacy of adalimumab in generalized pustular psoriasis.
Zangrilli A, Papoutsaki M, Talamonti M, Chimenti S.
Imiquimod for restoring local immunity in a renal transplant patient with persistent
keratoacanthoma.
Paternò EJ, Campione E, Diluvio L, Orlandi A, Chimenti S.
Dermatol Online J. 2008 Mar 15;14(3):8.
IKKalpha is a p63 transcriptional target involved in the pathogenesis of ectodermal dysplasias.
Marinari B, Ballaro C, Koster MI, Giustizieri ML, Moretti F, Crosti F, Papoutsaki M, Karin M,
Alema S, Chimenti S, Roop DR, Costanzo A.
J Invest Dermatol. 2009 Jan;129(1):60-9. Epub 2008 Jul 17.
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness.
Campione E, Paternò EJ, Diluvio L, Orlandi A, Bianchi L, Chimenti S.
Recent patents on melanoma with focus on genetic strategies.
Gramiccia T, Saraceno R, Stefani AD, Chimenti S.
Recent Pat Antiinfect Drug Discov. 2008 Jun;3(2):136-44. Review.
Recommendations for the long-term treatment of psoriasis with infliximab: a dermatology expert
group consensus.
Reich K, Griffiths C, Barker J, Chimenti S, Daudén E, Giannetti A, Gniadecki R, Katsambas A,
Langley R, Mrowietz U, Ogilvie A, Ortonne JP, Reider N, Saurat JH.
Dermatology. 2008;217(3):268-75. Epub 2008 Aug 6.
Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and
multiple squamous cell carcinomas in an elderly subject.
Saraceno R, Teoli M, Chimenti S.
Clin Ther. 2008 Jul;30(7):1324-9.
Bullous dermatomyositis: a marker of poor prognosis and aggressive internal malignancy?
Zangrilli A, Papoutsaki M, Bianchi L, Teoli M, Chimenti S.
Moderate and severe plaque psoriasis: cost-of-illness study in Italy.
Colombo G, Altomare G, Peris K, Martini P, Quarta G, Congedo M, Costanzo A, Di Cesare A,
Lapucci E, Chimenti S.
Ther Clin Risk Manag. 2008 Apr;4(2):559-68.
Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis.
Evidence from the Psocare project.
Naldi L, Addis A, Chimenti S, Giannetti A, Picardo M, Tomino C, Maccarone M, Chatenoud L,
Bertuccio P, Caggese E, Cuscito R.
Dermatology. 2008;217(4):365-73. Epub 2008 Sep 23.
Treatment of folliculitis with monochromatic excimer light (308 nm).
Nisticò SP, Saraceno R, Carboni I, Chimenti S.
Dermatology. 2009;218(1):33-6. Epub 2008 Oct 22.
The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta
antiproliferative pathway.
Marinari B, Moretti F, Botti E, Giustizieri ML, Descargues P, Giunta A, Stolfi C, Ballaro C,
Papoutsaki M, Alemà S, Monteleone G, Chimenti S, Karin M, Costanzo A.
Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17091-6. Epub 2008 Oct 28.
[Ashy dermatosis: clinico-pathological associations in two cases].
Carboni I, Costanzo A, Campione E, Paternò EJ, Chimenti S.
Clin Ter. 2008 Sep-Oct;159(5):321-3. Italian.
Does metabolic syndrome influence psoriasis?
Saraceno R, Ruzzetti M, De Martino MU, Di Renzo L, Cianci R, De Lorenzo A, Chimenti S.
Eur Rev Med Pharmacol Sci. 2008 Sep-Oct;12(5):339-41.
Etanercept provides a more physiological approach in the treatment of psoriasis.
Altomare G, Ayala F, Berardesca E, Chimenti S, Giannetti A, Girolomoni G, Lotti T, Martini P,
Peserico A, Guerra AP, Vena GA.
Dermatol Ther. 2008 Oct;21 Suppl 2:S1-14. Review.
Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the
Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For
Research and Treatment of Cancer (EORTC).
Kempf W, Ostheeren-Michaelis S, Paulli M, Lucioni M, Wechsler J, Audring H, Assaf C, Rüdiger
T, Willemze R, Meijer CJ, Berti E, Cerroni L, Santucci M, Hallermann C, Berneburg M, Chimenti
S, Robson A, Marschalko M, Kazakov DV, Petrella T, Fraitag S, Carlotti A, Courville P, Laeng H,
Knobler R, Golling P, Dummer R, Burg G; Cutaneous Lymphoma Histopathology Task Force
Group of the European Organization for Research and Treatment of Cancer.
Arch Dermatol. 2008 Dec;144(12):1609-17.
Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in
melanoma patients.
Rapanotti MC, Bianchi L, Ricozzi I, Campione E, Pierantozzi A, Orlandi A, Chimenti S, Federici
G, Bernardini S.
Br J Dermatol. 2009 Feb;160(2):338-44. Epub 2008 Dec 5.
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab
therapy.
Costanzo A, Talamonti M, Spallone G, Botti E, Chimenti MS, Papoutsaki M, Chimenti S.
Dermatology. 2009;218(2):146-50. Epub 2008 Oct 30.
Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell
carcinoma in seborrhoeic areas of the face.
Diluvio L, Campione E, Paternò EJ, Orlandi A, Terrinoni A, Chimenti S.
Infliximab in the treatment of plaque type psoriasis.
Saraceno R, Saggini A, Pietroleonardo L, Chimenti S.
Clin Cosmet Investig Dermatol. 2009 Apr 3;2:27-37.
Emerging treatments in the management of psoriasis: biological targeting with ustekinumab.
Papoutsaki M, Costanzo A, Chimenti S.
Clin Cosmet Investig Dermatol. 2009 May 22;2:95-103.
A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy.
Colombo GL, Di Matteo S, Peris K, Fargnoli MC, Esposito M, Mazzotta A, Chimenti S.
Clinicoecon Outcomes Res. 2009;1:53-9. Epub 2009 Oct 15.
Relation between animal-type melanoma and reduced nuclear expression of glutathione
Stransferase pi.
Orlandi A, Costantini S, Campione E, Ferlosio A, Amantea A, Bianchi L, Chimenti S, Spagnoli LG.
Dermatitis artefacta in sporadic sclerodermoid hepatitis C virus-associated porphyria cutanea tarda.
Giunta A, Demin F, Campione E, Chimenti S, Bianchi L.
J Eur Acad Dermatol Venereol. 2009 Jul;23(7):849-50. Epub 2008 Dec 22. No abstract available.
Risk factors of hypertension, diabetes and obesity in Italian psoriasis patients: a survey on
sociodemographic characteristics, smoking habits and alcohol consumption.
Altobelli E, Petrocelli R, Maccarone M, Altomare G, Argenziano G, Giannetti A, Peserico A, Vena
GA, Tiberti S, Chimenti S, Peris K.
Eur J Dermatol. 2009 May-Jun;19(3):252-6. Epub 2009 Feb 17.
Influence and variation of the body mass index in patients treated with etanercept for plaque-type
psoriasis.
Esposito M, Mazzotta A, Saraceno R, Schipani C, Chimenti S.
Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):219-25.
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers.
Costanzo A, Talamonti M, Botti E, Spallone G, Papoutsaki M, Chimenti S.
Dermatology. 2009;219(1):48-53. Epub 2009 Apr 16.
Methyl aminolaevulinate photodynamic therapy for the treatment of hidradenitis suppurativa and
pilonidal cysts.
Saraceno R, Teoli M, Casciello C, Chimenti S.
Photodermatol Photoimmunol Photomed. 2009 Jun;25(3):164-5.
Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis
patients.
Campione E, Mazzotta A, Paternò EJ, Diluvio L, Prinz JC, Chimenti S.
Acta Derm Venereol. 2009;89(3):288-91.
Different applications of monochromatic excimer light in skin diseases.
Nisticò SP, Saraceno R, Schipani C, Costanzo A, Chimenti S.
Photomed Laser Surg. 2009 Aug;27(4):647-54.
Skin diseases in Europe. Dermatooncology.
Sterry W, Chimenti S, MacKie R.
Eur J Dermatol. 2009 Jul-Aug;19(4):417-8. Review. No abstract available.
Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the
treatment of vitiligo: a controlled study.
Saraceno R, Nisticò SP, Capriotti E, Chimenti S.
Dermatol Ther. 2009 Jul-Aug;22(4):391-4.
Alice, Eloi, Magali and Robert: the lives of four patients with psoriasis and the therapeutic
approaches of eight European experts.
Dubertret L, Chimenti S, Christophers E, Daudén E, de Rie M, Griffiths CE, Kragballe K, Ståhle
M, Stingl G.
Br J Dermatol. 2009 Aug;161 Suppl 2:1-30. No abstract available.
Scalp psoriasis: European consensus on grading and treatment algorithm.
Ortonne J, Chimenti S, Luger T, Puig L, Reid F, Trüeb RM.
J Eur Acad Dermatol Venereol. 2009 Dec;23(12):1435-44. Epub 2009 Jul 15.
Dermatopathology.
Kerl H, Cerio R, Burg G, Anadolu RY, Chimenti S, Forsea D.
Eur J Dermatol. 2009 Sep-Oct;19(5):536-7. Epub 2009 Aug 6. No abstract available.
Efficacy and safety of etanercept in psoriasis after switching from other treatments: an
observational study.
Mazzotta A, Esposito M, Costanzo A, Chimenti S.
Am J Clin Dermatol. 2009;10(5):319-24. doi: 10.2165/11310770-000000000-00000.
Calcipotriene/betamethasone in the treatment of psoriasis: a review article.
Saraceno R, Gramiccia T, Frascione P, Chimenti S.
Expert Opin Pharmacother. 2009 Oct;10(14):2357-65. Review.
Is there an association between topiramate and granuloma annulare?
Ruzzetti M, Saraceno R, Peris K, Chimenti S.
J Eur Acad Dermatol Venereol. 2010 Feb;24(2):238-9. Epub 2009 Aug 13. No abstract available.
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis.
Caruso R, Botti E, Sarra M, Esposito M, Stolfi C, Diluvio L, Giustizieri ML, Pacciani V, Mazzotta
A, Campione E, Macdonald TT, Chimenti S, Pallone F, Costanzo A, Monteleone G.
Nat Med. 2009 Sep;15(9):1013-5. Epub 2009 Aug 16.
Urticaria associated with hyper-IgE in a patient with psoriasis undergoing treatment with
efalizumab.
Saraceno R, Scotto G, Chiricozzi A, Chimenti S.
European S3-guidelines on the systemic treatment of psoriasis vulgaris.
Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, Barker J, Bos JD, Burmester GR,
Chimenti S, Dubertret L, Eberlein B, Erdmann R, Ferguson J, Girolomoni G, Gisondi P, Giunta A,
Griffiths C, Hönigsmann H, Hussain M, Jobling R, Karvonen SL, Kemeny L, Kopp I, Leonardi C,
Maccarone M, Menter A, Mrowietz U, Naldi L, Nijsten T, Ortonne JP, Orzechowski HD, Rantanen
T, Reich K, Reytan N, Richards H, Thio HB, van de Kerkhof P, Rzany B.
J Eur Acad Dermatol Venereol. 2009 Oct;23 Suppl 2:1-70. Erratum in: J Eur Acad Dermatol
Venereol. 2010 Jan;24(1):117-8.
Skin diseases in Europe. Teledermatology.
Burg G, Soyer HP, Chimenti S.
Eur J Dermatol. 2009 Nov-Dec;19(6):656-8. Epub 2009 Sep 9. No abstract available.
Role of contrast-enhanced ultrasound in early diagnosis of psoriatic arthritis.
Solivetti FM, Elia F, Teoli M, De Mutiis C, Chimenti S, Berardesca E, Di Carlo A.
Dermatology. 2010;220(1):25-31. Epub 2009 Nov 11.
Long-term experience with etanercept in psoriatic arthritis patients: a 3-year observational study.
Mazzotta A, Esposito M, Schipani C, Chimenti S.
Why 3 mg/kg instead of 5 mg/kg of infliximab should work in psoriatic arthritis?
Di Renzo L, Saraceno R, Schipani C, Chimenti S, De Lorenzo A.
J Dermatol. 2009 Dec;36(12):666-8. No abstract available.
Topical treatment of actinic keratoses with piroxicam 1% gel: a preliminary open-label study
utilizing a new clinical score.
Campione E, Diluvio L, Paternò EJ, Chimenti S.
Am J Clin Dermatol. 2010;11(1):45-50. doi: 10.2165/11311170-000000000-00000.
Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia.
Campione E, Diluvio L, Paternò EJ, Di Marcantonio D, Francesconi A, Terrinoni A, Orlandi A,
Chimenti S.
Clin Ther. 2009 Nov;31(11):2565-9.
Radiologically significant joint improvement in a patient affected by psoriatic arthritis treated with
adalimumab.
Chimenti MS, Papoutsaki M, Teoli M, Zangrilli A, Perricone R, Chimenti S.
Clin Exp Rheumatol. 2009 Nov-Dec;27(6):1056. No abstract available.
Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis.
Diluvio L, Romiti ML, Angelini F, Campione E, Rossi P, Prinz JC, Chimenti S, Lamioni A.
Br J Dermatol. 2010 Apr;162(4):895-7. Epub 2010 Feb 25. No abstract available.
A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and
safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with
moderate to severe psoriasis: the BELIEVE study.
Thaçi D, Ortonne JP, Chimenti S, Ghislain PD, Arenberger P, Kragballe K, Saurat JH, Khemis A,
Sprøgel P, Esslinger HU, Unnebrink K, Kupper H.
Br J Dermatol. 2010 Aug;163(2):402-11. Epub 2010 Apr 2.
Evolution of and risk factors for psychological distress in patients with psoriasis: the PSYCHAE
study.
Colombo D, Caputo A, Finzi A, Andreassi L, Chimenti S, Vena GA, Giannetti A.
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different
human ectodermal dysplasias.
Moretti F, Marinari B, Lo Iacono N, Botti E, Giunta A, Spallone G, Garaffo G, Vernersson-Lindahl
E, Merlo G, Mills AA, Ballarò C, Alemà S, Chimenti S, Guerrini L, Costanzo A.
J Clin Invest. 2010 May;120(5):1570-7. doi: 10.1172/JCI40267. Epub 2010 Apr 26.
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant
to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial.
Lotti T, Chimenti S, Katsambas A, Ortonne JP, Dubertret L, Licu D, Simon J.
Arch Drug Inf. 2010 Mar;3(1):9-18.
An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo
nodularis.
Saraceno R, Chiricozzi A, Nisticò SP, Tiberti S, Chimenti S.
J Dermatolog Treat. 2010 Nov;21(6):363-6.
Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from
a national primary care database.
Vena GA, Altomare G, Ayala F, Berardesca E, Calzavara-Pinton P, Chimenti S, Giannetti A,
Girolomoni G, Lotti T, Martini P, Mazzaglia G, Peserico A, Puglisi Guerra A, Sini G, Cassano N,
Cricelli C.
Eur J Dermatol. 2010 Sep-Oct;20(5):593-8. Epub 2010 Jul 7.
Psoriasis disappearance after resection of a bladder tumour.
Ruzzetti M, Saraceno R, Fabiano S, Chimenti S.
Eur J Dermatol. 2010 Sep-Oct;20(5):646-7. Epub 2010 Jul 8. No abstract available.
Continuous treatment of plaque-type psoriasis with etanercept: an observational long-term
experience.
Esposito M, Giunta A, Mazzotta A, Babino G, Talamonti M, Chimenti MS, Chimenti S.
Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):503-9.
Mobile phones: a role in teaching dermatology?
Giunta A, Di Stefani A, Chimenti S.
Dermatology. 2011 Feb;222(1):22-3. Epub 2010 Aug 18. No abstract available.
Treatment of disfiguring chronic graft versus host disease in a child with topical pimecrolimus.
Zangrilli A, Campione E, Diluvio L, Paternò EJ, Orlandi A, Simone MD, Chimenti S.
Pediatr Int. 2010 Jun;52(3):e161-3. No abstract available.
Juvenile psoriasis and its clinical management: a European expert group consensus.
Ståhle M, Atakan N, Boehncke WH, Chimenti S, Daudén E, Giannetti A, Hoeger P, Joly P,
Katsambas A, Kragballe K, Lambert J, Ortonne JP, Prinz JC, Puig L, Seyger M, Strohal R, Van De
Kerkhoff P, Sterry W.
J Dtsch Dermatol Ges. 2010 Oct;8(10):812-8. doi: 10.1111/j.1610-0387.2010.07507.x. Epub 2010
Aug 25. English, German.
The impact of methodological approaches for presenting long-term clinical data on estimates of
efficacy in psoriasis illustrated by three-year treatment data on infliximab.
Papoutsaki M, Talamonti M, Giunta A, Costanzo A, Ruzzetti M, Teoli M, Chimenti S.
Dermatology. 2010;221 Suppl 1:43-7. Epub 2010 Aug 9.
Psoriasis: from pathogenesis to novel therapeutic approaches.
Monteleone G, Pallone F, MacDonald TT, Chimenti S, Costanzo A.
Clin Sci (Lond). 2011 Jan;120(1):1-11. Review.
Cost-effectiveness analysis of topical treatments for actinic keratosis in the perspective of the Italian
health care system.
Colombo GL, Chimenti S, Di Matteo S, Fargnoli MC, Frascione P, Silipo V, Peris K.
G Ital Dermatol Venereol. 2010 Oct;145(5):573-81.
Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory
pathogenic circuits in psoriasis.
Chiricozzi A, Guttman-Yassky E, Suárez-Fariñas M, Nograles KE, Tian S, Cardinale I, Chimenti S,
Krueger JG.
J Invest Dermatol. 2011 Mar;131(3):677-87. Epub 2010 Nov 18.
Efalizumab.
Talamonti M, Spallone G, Di Stefani A, Costanzo A, Chimenti S.
Expert Opin Drug Saf. 2011 Mar;10(2):239-51. Epub 2011 Jan 10. Review.
Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour
necrosis factor agents: subanalysis of BELIEVE.
Ortonne JP, Chimenti S, Reich K, Gniadecki R, Sprøgel P, Unnebrink K, Kupper H, Goldblum O,
Thaçi D.
J Eur Acad Dermatol Venereol. 2011 Sep;25(9):1012-20. doi: 10.1111/j.1468-3083.2010.03944.x.
Epub 2011 Jan 9.
Effects of TNF-α and IL-1 β on the activation of genes related to inflammatory, immune responses
and cell death in immortalized human HaCat keratinocytes.
Nisticò S, Paolillo N, Minella D, Piccirilli S, Rispoli V, Giardina E, Biancolella M, Chimenti S,
Novelli G, Nisticò G.
Int J Immunopathol Pharmacol. 2010 Oct-Dec;23(4):1057-72.
IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal
hyperplasia.
Sarra M, Caruso R, Cupi ML, Monteleone I, Stolfi C, Campione E, Diluvio L, Mazzotta A, Botti E,
Chimenti S, Costanzo A, MacDonald TT, Pallone F, Monteleone G.
J Immunol. 2011 May 1;186(9):5435-42. Epub 2011 Mar 25.
Patients with moderate to severe plaque psoriasis: one year after the European Medicines Agency
recommendation of efalizumab suspension.
Talamonti M, Teoli M, Botti E, Spallone G, Chimenti S, Costanzo A.
Dermatology. 2011;222(3):250-5. Epub 2011 Apr 13.
"Bathing trunk" eruption of papules and nodules in a young woman. Eruptive disseminated Spitz
naevi.
Saggini A, Di Stefani A, Saraceno R, Chimenti S.
Acta Derm Venereol. 2011 Oct;91(6):738-9. No abstract available.
Specific challenges in the management of subungual melanoma.
De Giorgi V, Saggini A, Grazzini M, Gori A, Rossari S, Scarfì F, Verdelli A, Chimenti S, Lotti T,
Massi D.
Expert Rev Anticancer Ther. 2011 May;11(5):749-61. Review.
Health-related quality of life in psoriasis: an analysis of Psocare project patients.
Spandonaro F, Altomare G, Berardesca E, Calzavara-Pinton P, Chimenti S, Girolomoni G, Peserico
A, Guerra AP, Vena GA, Polistena B, Ayala F.
G Ital Dermatol Venereol. 2011 Jun;146(3):169-77.
Exaggerated imiquimod application site reactions in the context of systemic tumor necrosis
factoralpha inhibition: more than a coincidental occurrence?
Saggini A, Saraceno R, Chimenti S.
Int J Immunopathol Pharmacol. 2011 Apr-Jun;24(2):509-15.
Cerebriform plantar hyperplasia: the clinico-pathological hallmark of Proteus syndrome.
Di Stefani A, Gabellini M, Ferlosio A, Spagnoli LG, Chimenti S, Orlandi A.
Acta Derm Venereol. 2011 Sep;91(5):580-1.
Etanercept, childhood and long-term safety: a case of five years treatment.
Mazzotta A, Saraceno R, Esposito M, Chimenti S.
Eur J Dermatol. 2011 Sep-Oct;21(5):776-7. No abstract available.
Efficacy and tolerability of 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in
wrinkle reduction of photodamaged skin.
Piccioni A, Fargnoli MC, Schoinas S, Suppa M, Frascione P, Ginebri A, Chimenti S, Peris K.
J Dermatolog Treat. 2011 Oct;22(5):247-53. doi: 10.3109/09546634.2011.590791. Epub 2011 Jul
31.
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas.
Botti E, Spallone G, Moretti F, Marinari B, Pinetti V, Galanti S, De Meo PD, De Nicola F, Ganci F,
Castrignanò T, Pesole G, Chimenti S, Guerrini L, Fanciulli M, Blandino G, Karin M, Costanzo A.
Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13710-5. Epub 2011 Aug 1.
Current psoriasis treatments in an Italian population and their association with socio-demographical
and clinical features.
Altobelli E, Marziliano C, Fargnoli MC, Petrocelli R, Maccarone M, Chimenti S, Peris K.
J Eur Acad Dermatol Venereol. 2011 Aug 4. doi: 10.1111/j.1468-3083.2011.04196.x.
Prospective assessment of body weight and body composition changes in patients with psoriasis
receiving anti-TNF-α treatment.
Renzo LD, Saraceno R, Schipani C, Rizzo M, Bianchi A, Noce A, Esposito M, Tiberti S, Chimenti
S, DE Lorenzo A.
Dermatol Ther. 2011 Jul-Aug;24(4):446-51. doi: 10.1111/j.1529-8019.2011.01439.x.
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma
screening strategies.
Seidenari S, Benati E, Ponti G, Borsari S, Ferrari C, Albertini G, Altomare G, Arcangeli F, Aste N,
Bernengo MG, Bongiorno MR, Borroni G, Calvieri S, Chimenti S, Cusano F, Fracchiolla C,
Gaddoni G, Girolomoni G, Guarneri B, Lanzoni A, Lombardi M, Lotti T, Mariotti A, Marsili F,
Micali G, Parodi A, Peris K, Peserico A, Quaglino P, Santini M, Schiavon S, Tonino C, Trevisan G,
Tribuzi P, Valentini P, Vena GA, Virgili A.
Eur J Cancer Prev. 2012 Jan;21(1):89-95.
Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized
controlled study.
Nisticò S, Chiricozzi A, Saraceno R, Schipani C, Chimenti S.
Photomed Laser Surg. 2012 Jan;30(1):26-30. Epub 2011 Nov 4.
Mycosis Fungoides in the Setting of T-cell Large Granular Lymphocyte Proliferative Disorder.
Saggini A, Saraceno R, Anemona L, Chimenti S, Di Stefani A.
Acta Derm Venereol. 2012 Jun 8;92(3):288-289. doi: 10.2340/00015555-1219.
Allele-specific cytokine responses at the HLA-C locus: implications for psoriasis.
Hundhausen C, Bertoni A, Mak RK, Botti E, Di Meglio P, Clop A, Laggner U, Chimenti S, Hayday
AC, Barker JN, Trembath RC, Capon F, Nestle FO.
J Invest Dermatol. 2012 Mar;132(3 Pt 1):635-41. doi: 10.1038/jid.2011.378. Epub 2011 Nov 24.
174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers.
Di Renzo L, Bianchi A, Saraceno R, Calabrese V, Cornelius C, Iacopino L, Chimenti S, De
Lorenzo A.
Pharmacogenet Genomics. 2012 Feb;22(2):134-42.
Emerging applications of nanomedicine in dermatology.
Saraceno R, Chiricozzi A, Gabellini M, Chimenti S.
Skin Res Technol. 2011 Dec 18. doi: 10.1111/j.1600-0846.2011.00601.x.
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target.
Botti E, Spallone G, Caruso R, Monteleone G, Chimenti S, Costanzo A.
Curr Pharm Biotechnol. 2012 Jan 17.
Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis.
Girolomoni G, Altomare G, Ayala F, Berardesca E, Calzavara-Pinton P, Chimenti S, Peserico A,
Puglisi Guerra A, Vena GA.
Immunopharmacol Immunotoxicol. 2012 Aug;34(4):548-60. Epub 2012 Feb 2.
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence
from the Italian Psocare Registry.
Gisondi P, Cazzaniga S, Chimenti S, Giannetti A, Maccarone M, Picardo M, Girolomoni G, Naldi
L; Psocare Study Group.
J Eur Acad Dermatol Venereol. 2012 Feb 7.
Double-blind, within-patient, randomized, clinical trial comparing fluorine-synthetic fiber socks
with standard cotton socks in improving plantar psoriasis.
Cazzaniga S, Lo Scocco G, Schincaglia E, Mercuri SR, Chimenti S, Saraceno R, Naldi L.
J Dermatolog Treat. 2012 Jun 5.
The role of antinuclear autoantibodies in patients with psoriasis treated with anti-tumor necrosis
factor-alpha agents: a retrospective long-term study.
Saraceno R, Specchio F, Torres T, Nisticò SP, Rizza S, Chimenti S.
J Am Acad Dermatol. 2012 May;66(5):e180-2.
Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with
adalimumab: a retrospective study.
Teoli M, Zangrilli A, Chimenti MS, Talamonti M, Bavetta M, Graceffa D, Perricone R, Chimenti S.
Clin Dev Immunol. 2012;2012:823854. Epub 2012 May 9.
Bowenoid Papulosis and Invasive Bowen's Disease: A Multidisciplinary Approach.
Campione E, Centonze C, Diluvio L, Orlandi A, Cipriani C, Di Stefani A, Piccione E, Chimenti S,
Bianchi L.
Acta Derm Venereol. 2012 Jun 21. doi: 10.2340/00015555-1328.
Etanercept provides an effective, safe and flexible short- and long-term treatment regimen for
moderate-to-severe psoriasis: a systematic review of current evidence.
Strohal R, Chimenti S, Vena GA, Girolomoni G.
J Dermatolog Treat. 2012 Nov 10. [Epub ahead of print]
New insights into the pathogenesis of cutaneous autoimmune disorders.
Chiricozzi A, Zhang S, Dattola A, Cannizzaro MV, Gabellini M, Chimenti S, Nistico SP.
J Biol Regul Homeost Agents. 2012 Apr-Jun;26(2):165-70.
Ustekinumab for treatment of plaque psoriasis in a patient with Down syndrome.
Talamonti M, Galluzzo M, Chiricozzi A, Teoli M, Bavetta M, Costanzo A, Chimenti S.
J Drugs Dermatol. 2012 Aug;11(8):1000-2.
Role of Th17 in the pathogenesis of cutaneous inflammatory diseases.
Chiricozzi A, Zhang S, Dattola A, Gabellini M, Chimenti S, Nistico SP.
J Biol Regul Homeost Agents. 2012 Jul-Sep;26(3):313-8. Review.
HIV-associated primary cutaneous anaplastic large cell lymphoma: a clinicopathological subset
with more aggressive behavior? Case report and review of the literature.
Saggini A, Anemona L, Chimenti S, Sarmati L, Torti C, Di Stefani A, Bianchi L.
J Cutan Pathol. 2012 Dec;39(12):1100-9. doi: 10.1111/cup.12020. Epub 2012 Oct 13.
Entecavir and Intermittent Etanercept Therapy in a Patient with Concurrent Hepatitis B Virus
Infection and Psoriasis.
Babino G, Esposito M, Mazzotta A, Chimenti S, Giunta A.
Acta Derm Venereol. 2012 Nov 13. doi: 10.2340/00015555-1477. [Epub ahead of print]
Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the
treatment of plaque psoriasis.
Girolomoni G, Vena GA, Ayala F, Cannavò SP, De Pità O, Chimenti S, Peserico A.
G Ital Dermatol Venereol. 2012 Dec;147(6):609-24.
TNF-α antagonists and nail psoriasis: an open, 24-week, prospective cohort study in adult patients
with psoriasis.
Saraceno R, Pietroleonardo L, Mazzotta A, Zangrilli A, Bianchi L, Chimenti S.
Expert Opin Biol Ther. 2013 Apr;13(4):469-73. doi: 10.1517/14712598.2013.736960. Epub 2012
Nov 16.
Prevalence and management of panic attacks during infliximab infusion in psoriatic patients.
Saraceno R, Faleri S, Ruzzetti M, Centonze D, Chimenti S.
Dermatology. 2012;225(3):236-41. doi: 10.1159/000343609. Epub 2012 Nov 22.
Lung Nodule and Facial Erythematous Plaques: A Quiz.
Carboni I, Montaldo M, Chimenti S, Di Stefani A, Ambrogi V.
Acta Derm Venereol. 2012 Dec 7. doi: 10.2340/00015555-1489. [Epub ahead of print]
Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and
adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational longterm study.
Esposito M, Giunta A, Mazzotta A, Zangrilli A, Babino G, Bavetta M, Perricone R, Chimenti S,
Chimenti MS.
Dermatology. 2012;225(4):312-9. doi: 10.1159/000345623. Epub 2012 Dec 28.
Complete resolution of erythrodermic psoriasis in an HIV and HCV patient unresponsive to
antipsoriatic treatments after highly active antiretroviral therapy (Ritonavir, Atazanavir,
Emtricitabine, Tenofovir).
Chiricozzi A, Saraceno R, Cannizzaro MV, Nisticò SP, Chimenti S, Giunta A.
Dermatology. 2012;225(4):333-7. doi: 10.1159/000345762. Epub 2012 Dec 28.
[New functions and applications of vitamin D in internal medicine].
Carboni I, Campione E, Specchio F, Chimenti S.
Clin Ter. 2012 Nov;163(6):e441-4. Italian.
Inflammatory linear verrucous epidermal nevus and epilepsy: remission during valproic acid
therapy.
Diluvio L, Campione E, Mordenti C, Bagnolo V, Cerminara C, Chimenti S, Bianchi L.
J Drugs Dermatol. 2013 Jan;12(1):18-9. No abstract available.
Pharmacogenetics of Psoriasis: HLACw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism
predisposes to clinical response to IL12/23 blocker ustekinumab.
Talamonti M, Botti E, Galluzzo M, Teoli M, Spallone G, Bavetta M, Chimenti S, Costanzo A.
Br J Dermatol. 2013 Mar 23. doi: 10.1111/bjd.12331. [Epub ahead of print]
Confocal reflectance microscopy in pityriasis rubra pilaris.
Pietroleonardo L, Di Stefani A, Campione E, Chimenti S, Orlandi A, Bianchi L.
J Am Acad Dermatol. 2013 Apr;68(4):689-91. doi: 10.1016/j.jaad.2012.10.043. No abstract
available.
Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris.
Di Stefani A, Galluzzo M, Talamonti M, Chiricozzi A, Costanzo A, Chimenti S.
J Dermatol Case Rep. 2013 Mar 30;7(1):5-9. doi: 10.3315/jdcr.2013.1127. Print 2013 Mar 30.
Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone
dipropionate gel (Xamiol® gel) in the treatment of scalp psoriasis: results from a study in 885
patients.
Saraceno R, Camplone G, D'Agostino M, De Simone C, Di Cesare A, Filosa G, Frascione P,
Gabellini M, Lunghi F, Mazzotta A, Peris K, Scotto Di Luzio G, Calvieri S, Simonacci M,
Chimenti S.
J Dermatolog Treat. 2014 Feb;25(1):30-3.
Profile of certolizumab and its potential in the treatment of psoriatic arthritis.
Chimenti MS, Saraceno R, Chiricozzi A, Giunta A, Chimenti S, Perricone R.
Drug Des Devel Ther. 2013 Apr 15;7:339-48. doi: 10.2147/DDDT.S31658. Print 2013.
Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone
dipropionate gel (Xamiol® gel) in the treatment of scalp psoriasis: results from a study in 885
patients.
Saraceno R, Camplone G, D'Agostino M, De Simone C, Di Cesare A, Filosa G, Frascione P,
Gabellini M, Lunghi F, Mazzotta A, Peris K, Scotto Di Luzio G, Calvieri S, Simonacci M,
Chimenti S.
J Dermatolog Treat. 2014 Feb;25(1):30-3.
Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological
practice: a multicentre observational study.
Esposito M, Gisondi P, Cassano N, Ferrucci G, Del Giglio M, Loconsole F, Giunta A, Vena GA,
Chimenti S, Girolomoni G.
Br J Dermatol. 2013 Sep;169(3):666-72.
Benign dermoscopic features in melanoma.
Di Stefani A, Massone C, Soyer HP, Zalaudek I, Argenziano G, Arzberger E, Lozzi GP, Chimenti
S, Hofmann-Wellenhof R.
J Eur Acad Dermatol Venereol. 2014 Jun;28(6):799-804.
A case of pemphigus foliaceus successfully treated with anti-Ig-Ab immunoadsorption.
Saraceno R, Faleri S, Chimenti S, Lanti A, Adorno G, Lorè B.
Transfus Apher Sci. 2013 Aug;49(1):87-9.
The significance of the development of antinuclear antibodies during infliximab treatment.
Saraceno R, Chimenti MS, Chimenti S.
J Am Acad Dermatol. 2013 Aug;69(2):314
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis.
Saraceno R, Bavetta M, Zangrilli A, Chiricozzi A, Potenza C, Chimenti S, Chimenti MS.
Expert Opin Biol Ther. 2013 Sep;13(9):1325-34.
Infliximab in psoriasis and psoriatic arthritis.
Papoutsaki M, Osório F, Morais P, Torres T, Magina S, Chimenti S, Costanzo A.
BioDrugs. 2013 Jan;27 Suppl 1:13-23.
Remission of psoriatic arthritis after etanercept discontinuation: analysis of patients' clinical
characteristics leading to disease relapse.
Chimenti MS, Esposito M, Giunta A, Graceffa D, Babino G, Teoli M, Mazzotta A, Pericone R,
Chimenti S.
Int J Immunopathol Pharmacol. 2013 Jul-Sep;26(3):833-8.
Genetic markers for cardiovascular disease in psoriasis: the missing piece.
Torres T, Chiricozzi A, Chimenti S, Saraceno R.
Mol Diagn Ther. 2014 Feb;18(1):93-5.
Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease
severity.
Di Cesare A, Riitano A, Suppa M, Fidanza R, Zangrilli A, Esposito M, Fargnoli MC, Chimenti S,
Peris K.
J Am Acad Dermatol. 2013 Dec;69(6):947-53.
One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from
inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque
psoriasis.
Reich K, Puig L, Paul C, Kragballe K, Luger T, Lambert J, Chimenti S, Girolomoni G, Nicolas JF,
Rizova E, Brunori M, Mistry S, Bergmans P, Barker J; TRANSIT Investigators.
Br J Dermatol. 2014 Feb;170(2):435-44.
Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to
methotrexate: a randomized clinical trial (TRANSIT).
Paul C, Puig L, Kragballe K, Luger T, Lambert J, Chimenti S, Girolomoni G, Nicolas JF, Rizova E,
Lavie F, Mistry S, Bergmans P, Barker J, Reich K; TRANSIT Investigators.
Br J Dermatol. 2014 Feb;170(2):425-34.
Genetic variations in IL6 and IL12B decreasing the risk for psoriasis.
Boca AN, Talamonti M, Galluzzo M, Botti E, Vesa SC, Chimenti S, Buzoianu AD, Costanzo A.
Immunol Lett. 2013 Nov-Dec;156(1-2):127-31.
High density cholesterol level as predictor of clinical response to anti-TNF-alpha therapy in
psoriatic patients.
Saraceno R, Rizza S, Faleri S, Federici M, Nistico SP, Copetti M, Chimenti S.
J Biol Regul Homeost Agents. 2013 Jul-Sep;27(3):903-8.
Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: a report of two
cases.
Saraceno R, Talamonti M, Galluzzo M, Chiricozzi A, Costanzo A, Chimenti S.
Case Rep Dermatol. 2013 Sep 26;5(3):254-9.
Betamethasone valerate dressing is non-inferior to calcipotriol-betamethasone dipropionate
ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: results of a
randomized assessor-blinded multicentre trial.
Ortonne JP, Esposito M, Chimenti S, Kapińska-Mrowiecka M, Grodzińska A, Naldi L, Frangione
V.
J Eur Acad Dermatol Venereol. 2013 Oct 29.
Golimumab in patients affected by moderate to severe psoriatic arthritis: an open-label study in
thirty-two patients previously treated with other biologics.
Chimenti MS, Teoli M, Saraceno R, Dattola A, Ventura A, Chiricozzi A, Chiaramonte C, Perricone
R, Chimenti S.
Dermatology. 2013;227(4):305-10.
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour
necrosis factor blockers.
Saraceno R, Specchio F, Chiricozzi A, Sarmati L, Amicosante M, Chimenti MS, Chimenti S.
Expert Opin Biol Ther. 2014 Feb;14(2):151-6.
Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the
Italian Psocare registry.
Piaserico S, Cazzaniga S, Chimenti S, Giannetti A, Maccarone M, Picardo M, Peserico A, Naldi L;
Psocare Study Group.
J Am Acad Dermatol. 2014 Feb;70(2):257-62.e3.
New topical treatments for psoriasis.
Chiricozzi A, Pitocco R, Saraceno R, Nistico SP, Giunta A, Chimenti S.
Expert Opin Pharmacother. 2014 Mar;15(4):461-70.
Randomized, within-patient, clinical trial comparing fluorine-synthetic fiber socks with standard
cotton socks in improving plantar pustulosis.
Cazzaniga S, Lo Scocco G, Schincaglia E, Mercuri SR, Chimenti S, Saraceno R, Naldi L.
Dermatology. 2014;228(2):166-71.
Chronically Sun-damaged Melanomas Express Low Levels of Nuclear Glutathione-S-transferase-π:
An Epidemiological and Clinicopathological Study in Italy.
Campione E, Medda E, Paternò EJ, Diluvio L, Ricozzi I, Carboni I, Costanza G, Rossi P, Rapanotti
C, Di Stefani A, Chimenti S, Bianchi L, Orlandi A.
Acta Derm Venereol. 2014 Feb 17. doi: 10.2340/00015555-1821.
The cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real
practice settings in Italy.
Spandonaro F, Ayala F, Berardesca E, Chimenti S, Girolomoni G, Martini P, Peserico A, Polistena
B, Puglisi Guerra A, Vena GA, Altomare G, Calzavara Pinton P.
BioDrugs. 2014 Jun;28(3):285-95.
Cutaneous manifestations in patients with chronic renal failure on hemodialysis.
Specchio F, Carboni I, Chimenti S, Tamburi F, Nistico' S.
Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1):1-4
Management of non-melanoma skin cancer in solid organ transplant recipients.
Specchio F, Saraceno R, Chimenti S, Nistico S.
Differential management of mild-to-severe psoriasis with biologic drugs: An Italian Delphi
consensus expert panel.
Girolomoni G, Altomare G, Ayala F, Berardesca E, Calzavara Pinton P, Chimenti S, Martini P,
Peserico A, Puglisi Guerra A, Antonio Vena G; on behalf on the Delphi working group.
J Dermatolog Treat. 2014 Apr 8.
Dermoscopy as an adjuvant tool for detecting skin leiomyomas in patient with uterine fibroids and
cerebral cavernomas.
Diluvio L, Torti C, Terrinoni A, Candi E, Piancatelli R, Piccione E, Paternò EJ, Chimenti S,
Orlandi A, Campione E, Bianchi L.
BMC Dermatol. 2014 Apr 16;14(1):7.
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases.
Blandizzi C, Gionchetti P, Armuzzi A, Caporali R, Chimenti S, Cimaz R, Cimino L, Lapadula G,
Lionetti P, Marchesoni A, Marcellusi A, Mennini FS, Salvarani C, Girolomoni G.
Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):1-10.
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on
adalimumab.
Armuzzi A, Lionetti P, Blandizzi C, Caporali R, Chimenti S, Cimino L, Gionchetti P, Girolomoni
G, Lapadula G, Marchesoni A, Marcellusi A, Mennini FS, Salvarani C, Cimaz R.
Adalimumab in the treatment of immune-mediated diseases.
Lapadula G, Marchesoni A, Armuzzi A, Blandizzi C, Caporali R, Chimenti S, Cimaz R, Cimino L,
Gionchetti P, Girolomoni G, Lionetti P, Marcellusi A, Mennini FS, Salvarani C.
Prevalence of past and reactivated viral infections and efficacy of cyclosporine A as monotherapy
or in combination in patients with psoriatic arthritis--synergy study: a longitudinal observational
study.
Colombo D, Chimenti S, Grossi P, Marchesoni A, Di Nuzzo S, Griseta V, Gargiulo A, Parodi A,
Simoni L, Bellia G.
Biomed Res Int. 2014;2014:941767.
Relapsed actinic keratosis evaluation: an observational Italian multicenter prospective study. Does
gender have a role?
Javor S, Chimenti S, Patrizi A, Stingeni L, Pellacani G, Cavicchini S, Sala R, Rongioletti F, Parodi
A.
G Ital Dermatol Venereol. 2014 Apr;149(2):199-204.
Topical lactoferrin can improve stable psoriatic plaque.
Saraceno R, Gramiccia T, Chimenti S, Valenti P, Pietropaoli M, Bianchi L.
G Ital Dermatol Venereol. 2014 Jun;149(3):335-40.
Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease
biomarker related to clinical outcome in melanoma.
Rapanotti MC, Suarez Viguria TM, Costanza G, Ricozzi I, Pierantozzi A, Di Stefani A, Campione
E, Bernardini S, Chimenti S, Orlandi A, Bianchi L.
Arch Dermatol Res. 2014 Jun 7.
Thymic stromal lymphopoietin links keratinocytes and dendritic cell-derived IL-23 in patients with
psoriasis.
Volpe E, Pattarini L, Martinez-Cingolani C, Meller S, Donnadieu MH, Bogiatzi SI, Fernandez MI,
Touzot M, Bichet JC, Reyal F, Paronetto MP, Chiricozzi A, Chimenti S, Nasorri F, Cavani A,
Kislat A, Homey B, Soumelis V.
J Allergy Clin Immunol. 2014 Jun 5. pii: S0091-6749(14)00597-1.
Immunologic biomarkers for clinical and therapeutic management of psoriasis.
Cordiali-Fei P, Bianchi L, Bonifati C, Trento E, Ruzzetti M, Francesconi F, Bultrini S, D'Agosto G,
Bordignon V, Francavilla V, Tripiciano A, Chiricozzi A, Campione E, Cavallotti C, Orlandi A,
Berardesca E, Di Carlo A, Chimenti S, Ensoli F.
Mediators Inflamm. 2014;2014:236060.
Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebocontrolled phase 2 trial.
Vaclavkova A, Chimenti S, Arenberger P, Holló P, Sator PG, Burcklen M, Stefani M, D'Ambrosio
D.
Lancet. 2014 Dec 6;384(9959):2036-45.
IL-6 as a druggable target in psoriasis: focus on pustular variants.
Saggini A, Chimenti S, Chiricozzi A.
J Immunol Res. 2014;2014:964069.
The first skin cancer screening day at the Italian parliament: a Euromelanoma initiative.
Suppa M, Neri L, Bianchi L, Capizzi R, Carbone A, Catricalà C, Chimenti S, Fargnoli MC, Fossati
B, Frascione P, Peris K.
Int J Dermatol. 2015 Jan;54(1):42-9.
Severe erytrodermic psoriasis in child twins: from clinical-pathological diagnosis to treatment of
choice through genetic analyses: two case reports.
Campione E, Diluvio L, Terrinoni A, Orlandi A, Latino MP, Torti C, Pietroleonardo L, Botti E,
Chimenti S, Bianchi L.
BMC Res Notes. 2014 Dec 17;7:929.
What happened after the clinical trials: long-term safety and efficacy of ustekinumab in daily
clinical practice.
Talamonti M, Galluzzo M, Bianchi L, Boca AN, Costanzo A, Chimenti S.
Dermatology. 2014;229(4):324-32.
Treatment adherence to different etanercept regimens, continuous vs. intermittent, in patients
affected by plaque-type psoriasis.
Esposito M, Gisondi P, Cassano N, Babino G, Cannizzaro MV, Ferrucci G, Chimenti S, Giunta A.
Drug Dev Res. 2014 Nov;75 Suppl 1:S31-4.
Clinical markers predictive of primary inefficacy: a "real life" retrospective study in psoriatic
patients treated with etanercept.
Giunta A, Babino G, Manetta S, Mazzotta A, Chimenti S, Esposito M.
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations.
Marinari B, Botti E, Bavetta M, Spallone G, Zangrilli A, Talamonti M, Richetta A, Chimenti S,
Costanzo A.
Unconventional use of intense pulsed light.
Piccolo D, Di Marcantonio D, Crisman G, Cannarozzo G, Sannino M, Chiricozzi A, Chimenti S.
Biomed Res Int. 2014;2014:618206.
Consensus on the use of cyclosporine in dermatological practice. Italian Consensus Conference.
Altomare G, Ayala F, Bardazzi F, Bellia G, Chimenti S, Colombo D, Flori ML, Girolomoni G,
Micali G, Parodi A, Peris K, Vena GA; Italian Consensus Conference.
Apheresis in the treatment of recalcitrant atopic dermatitis: case series and review of the literature.
Chiricozzi A, Faleri S, Lanti A, Adorno G, Lorè B, Chimenti S, Saraceno R.
Eur J Dermatol. 2014 Sep-Oct;24(5):545-50.
Consensus on the use of cyclosporine in dermatological practice. Italian Consensus Conference.
Altomare G, Ayala F, Bardazzi F, Bellia G, Chimenti S, Colombo D, Flori ML, Girolomoni G,
Micali G, Parodi A, Peris K, Vena GA; Italian Consensus Conference.
Unconventional use of intense pulsed light.
Piccolo D, Di Marcantonio D, Crisman G, Cannarozzo G, Sannino M, Chiricozzi A, Chimenti S.
Biomed Res Int. 2014;2014:618206. doi: 10.1155/2014/618206. Epub 2014 Sep 3.
Basal cell carcinoma: clinical and pathological features.
Di Stefani A, Chimenti S.
G Ital Dermatol Venereol. 2015 Jun 23. [Epub ahead of print]
Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome.
Saraceno R, Lore' B, Pavlidis A, Karaiskou M, Arcuri C, Chimenti S, Magnato R.
G Ital Dermatol Venereol. 2015 Jun 19. [Epub ahead of print]
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe
plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial
Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1).
Papp K, Reich K, Leonardi CL, Kircik L, Chimenti S, Langley RG, Hu C, Stevens RM, Day RM,
Gordon KB, Korman NJ, Griffiths CE.
J Am Acad Dermatol. 2015 Jul;73(1):37-49. doi: 10.1016/j.jaad.2015.03.049. Similar articles
Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3
randomised non-inferiority trial.
Bachelez H, van de Kerkhof PC, Strohal R, Kubanov A, Valenzuela F, Lee JH, Yakusevich V,
Chimenti S, Papacharalambous J, Proulx J, Gupta P, Tan H, Tawadrous M, Valdez H, Wolk R;
OPT Compare Investigators.
Lancet. 2015 Jun 4. pii: S0140-6736(14)62113-9. doi: 10.1016/S0140-6736(14)62113-9. [Epub
ahead of print]
Linear psoriasis following the typical distribution of the sciatic nerve.
Galluzzo M, Talamonti M, Di Stefani A, Chimenti S.
J Dermatol Case Rep. 2015 Mar 31;9(1):6-11. doi: 10.3315/jdcr.2015.1189. eCollection 2015 Mar
31.
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study.
Lolli E, Saraceno R, Calabrese E, Ascolani M, Scarozza P, Chiricozzi A, Onali S, Petruzziello C,
Chimenti S, Pallone F, Biancone L.
J Crohns Colitis. 2015 Apr 23. pii: jjv068. [Epub ahead of print]
Aphthous, coeliac disease and other dental disorders in childhood.
Saraceno R, Perugia C, Ventura A, Lore' B, Chimenti S, Docimo R.
G Ital Dermatol Venereol. 2015 Apr 9. [Epub ahead of print]
Cyclosporine in psoriasis: comparison of a 25-year real world Italian experience to current
European guidelines.
Altomare G, Ayala F, Bardazzi F, Bellia G, Chimenti S, Colombo D, Flori M, Girolomoni G,
Micali G, Parodi A, Peris K, Vena G.
G Ital Dermatol Venereol. 2015 Mar 19. [Epub ahead of print]
Tazarotene as alternative topical treatment for onychomycosis.
Campione E, Paternò EJ, Costanza G, Diluvio L, Carboni I, Marino D, Favalli C, Chimenti S,
Bianchi L, Orlandi A.
Drug Des Devel Ther. 2015 Feb 16;9:879-86. doi: 10.2147/DDDT.S69946. eCollection 2015.
Tofacitinib for the treatment of moderate-to-severe psoriasis.
Chiricozzi A, Faleri S, Saraceno R, Bianchi L, Buonomo O, Chimenti S, Chimenti MS.
Expert Rev Clin Immunol. 2015 Apr;11(4):443-55. doi: 10.1586/1744666X.2015.1013534. Epub
2015 Feb 10.
Reply to Scalone and Cortesi: "Cost-utility analysis of biologic therapies to treat chronic plaque
psoriasis in Italy: the importance of using updated and adequate social tariffs to calculate QALYs".
Spandonaro F, Ayala F, Berardesca E, Chimenti S, Girolomoni G, Martini P, Peserico A, Polistena
B, Guerra AP, Vena GA, Altomare G, Pinton PC.
BioDrugs. 2015 Feb;29(1):71-2. doi: 10.1007/s40259-015-0118-5. No abstract available.
Dermoscopic variability of basal cell carcinoma according to clinical type and anatomic location.
Suppa M, Micantonio T, Di Stefani A, Soyer HP, Chimenti S, Fargnoli MC, Peris K.
J Eur Acad Dermatol Venereol. 2015 Jan 28. doi: 10.1111/jdv.12980. [Epub ahead of print]
Severe erytrodermic psoriasis in child twins: from clinical-pathological diagnosis to treatment of
choice through genetic analyses: two case reports.
Campione E, Diluvio L, Terrinoni A, Orlandi A, Latino MP, Torti C, Pietroleonardo L, Botti E,
Chimenti S, Bianchi L.
BMC Res Notes. 2014 Dec 17;7:929. doi: 10.1186/1756-0500-7-929.
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk.
Chiricozzi A, Bianchi L, Zangrilli A, Bavetta M, Giunta A, Chimenti S, Saraceno R.
Eur J Dermatol. 2015 Jan-Feb;25(1):64-9. doi: 10.1684/ejd.2014.2473.
PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor
necrosis factor inhibition.
Saraceno R, Babino G, Chiricozzi A, Zangrilli A, Chimenti S.
J Am Acad Dermatol. 2015 Jan;72(1):e42-4. doi: 10.1016/j.jaad.2014.10.002. No abstract available.
What happened after the clinical trials: long-term safety and efficacy of ustekinumab in daily
clinical practice.
Talamonti M, Galluzzo M, Bianchi L, Boca AN, Costanzo A, Chimenti S.
Dermatology. 2014;229(4):324-32. doi: 10.1159/000365077. Epub 2014 Nov 15.
Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian
Psocare Registry.
Gisondi P, Cazzaniga S, Chimenti S, Maccarone M, Picardo M, Girolomoni G, Naldi L; Psocare
Study Group.
Br J Dermatol. 2015 Jun;172(6):1613-20. doi: 10.1111/bjd.13539. Epub 2015 Mar 17.
Treatment adherence to different etanercept regimens, continuous vs. intermittent, in patients
affected by plaque-type psoriasis.
Esposito M, Gisondi P, Cassano N, Babino G, Cannizzaro MV, Ferrucci G, Chimenti S, Giunta A.
Drug Dev Res. 2014 Nov;75 Suppl 1:S31-4. doi: 10.1002/ddr.21190.
Clinical markers predictive of primary inefficacy: a "real life" retrospective study in psoriatic
patients treated with etanercept.
Giunta A, Babino G, Manetta S, Mazzotta A, Chimenti S, Esposito M.
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations.
Marinari B, Botti E, Bavetta M, Spallone G, Zangrilli A, Talamonti M, Richetta A, Chimenti S,
Costanzo A.
LIBRI:
CHIMENTI S (2005). Il melanoma cutaneo: dalla ricerca scientifica alla pratica clinica.
CHIMENTI S (2005). Psoriasis.
P.L.AMERIO, M. G .BERNENGO, S. CALVIERI, CHIMENTI S, M. PIPPIONE (2003).
Dermatologia e Venereologia.
CHIMENTI S, GIUSEPPE ARGENZIANO, MD, NAPLES, H. PETER SOYER, MD, GRAZ,
VINCENZO DE GIORGI, MD, FLORENCE, DOMENICO PICCOLO, MD, LAQUILA, PAOLO
CARLI, MD, FLORENCE, MARIO DELFINO, MD, NAPLES, ANGELA FERRARI, MD,
LAQUILA, RAINER HOFMANN-WELLENHOF, MD, GRAZ, DANIELA MASSI, MD,
FLORENCE, GIAMPIERO MAZZOCCHETTI, MD, LAQUILA, MASSIMILIANO
SCALVENZI, MD, NAPLES, INGRID H. WOLF, MD, GRAZ (2000).
Interactive Atlas of Dermoscopy.
P.L.AMERIO, M. G .BERNENGO, S. CALVIERI, CHIMENTI S, M. PIPPIONE (2009).
Dermatologia e Venereologia.

Sergio Chimenti - Policlinico Tor Vergata

Transcript

Documenti analoghi

Manassero negli Usa, l`ultima da dilettante

ENCELADO Twin Crema 2x75ml

Dr.ssa Rosita Saraceno - Policlinico Tor Vergata

scheda pdf - Advanced Medical Aesthetic Solutions

Terapia topica in ambito dermatologico

Dermatologici

Supplemento N.1 - 2008

birra saison formati note tecniche

lipodissolve evolution: nuova frontiera in medicina

FORMATO EUROPEO PER IL CURRICULUM VITAE